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SUMMARY 
 
      Matrix metalloproteinases (MMPs) are involved in a variety of biological processes by 
their ability of remodelling the extracellular microenvironment, modulating the activity of 
transmembrane receptors and regulating signaling cascades. Membrane type-MMPs  
(MT1-, MT2-, MT3- and MT5-MMP) mainly act in pericellular proteolysis but they could also 
connect to intracellular events through their interaction with cytosolic proteins. We 
hypothesize that binding of MT-MMP cysolic tails to distinct partners can contribute to their 
specific functions. In this work, we have identified novel binding proteins of the MT-MMP 
cytosolic tails, characterized the residues involved in these interactions and explored their 
possible biological functions. The tyrosine present in the middle region of MT1-MMP 
cytosolic tail has been shown to be necessary for p130Cas binding and this binding 
participates in the promotion of myeloid progenitor migration and fusion. MT1-, MT2- and 
MT3-MMP have been shown to bind the ERM protein moesin; juxtamembrane and middle 
polybasic regions of MT1-MMP cytosolic tail act as key binding domains for this interaction 
that may be regulating MT1-MMP localization at the plasma membrane. Finally, ZO-1 has 
been identified as a differentially associated protein of MT-MMPs; MT2-, MT3- and MT5-
MMP are able to bind ZO-1 in contrast to MT1-MMP. Essential residues in the PDZ binding 
motif responsible for this different association pattern have also been identified. We have 
also observed that MT2-MMP colocalizes with ZO-1 in MT2-MMP stably transfected MDCK 
cells and that MT2-MMP expression affects F-actin polarization in these epithelial cells. In 
summary, this work identifies three actin-linker proteins as new molecular partners 
differentially associated with MT-MMPs; this differential association may contribute to MT-
MMP specific functions in diverse pathophysiological scenarios.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESUMEN 
 
      Las metaloproteinasas de matriz (MMPs) están implicadas en varios procesos 
biológicos por su capacidad de remodelar el microambiente extracelular, modular la 
actividad de los receptores transmembrana y regular las cascadas de señalización celular. 
Las MMPs de membrana (MT1-, MT2-, MT3- y MT5-MMP) actúan principalmente en la 
proteolisis pericelular pero pueden además participar en los eventos intracelulares a través 
de su interacción con proteínas citosólicas. Nuestra hipótesis es que la interacción de las 
colas citosólicas de las MT-MMP a distintas proteínas puede contribuir a sus funciones 
específicas. En este trabajo hemos identificado nuevas proteínas que interaccionan con las 
colas citosólicas de las MT-MMPs, caracterizándose los residuos implicados en estas 
interacciones y explorándose sus posibles funciones biológicas. Se ha demostrado que la 
tirosina presente en la región central de la cola citosólica de MT1-MMP es necesaria para 
la unión de p130Cas y esta unión participa en la migración y fusión de los progenitores 
mieloides. Se ha detectado la unión de MT1-, MT2- y MT3-MMP a la proteína ERM 
moesina; las regiones polibásicas yuxtamembranal y central de la cola citosólica de MT1-
MMP actúan como dominios clave y pueden regular la localización de MT1-MMP en la 
membrana plasmática. Finalmente, ZO-1 ha sido identificada como una proteína 
diferencialmente asociada a las MT-MMPs; MT2-, MT3- y MT5-MMP son capaces de 
interaccionar con ZO-1 al contrario que MT1-MMP. Los residuos en el motivo de unión a 
dominios PDZ responsables de este diferente patrón de asociación han sido también 
identificados. Además, hemos observado que MT2-MMP colocaliza con ZO-1 en células 
MDCK transfectadas establemente con MT2-MMP y que la expresión de MT2-MMP afecta 
la polarización de F-actina en estas células epiteliales. En resumen, en este trabajo se han 
identificado tres proteínas de unión a actina como nuevas proteínas asociadas 
diferencialmente a las MT-MMPs; esta asociación diferencial puede contribuir a las 
funciones específicas de las MT-MMP en distintos escenarios fisiopatológicos. 
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1. The matrix metalloproteinases (MMPs) 
                                                                                                         
The matrix metalloproteinases or matrixins (MMPs) are zinc dependent endopeptidases that 
belong to the metzincin superfamily (Nagase and Woessner, 1999). This superfamily is also 
formed of the following families: disintegrin and metalloproteinases (ADAMs) (White, 2003), the 
ADAMs with a thrombospondin motif (ADAMTS) (Tang, 2001), the bacterial serralysins 
(Nakahama et al., 1986) and other proteinases such as the astacins (including the meprins) 
(Bode et al., 1992). 
 
The MMP family is composed of 23 members in humans. The first member of the matrix 
metalloproteinase family was identified in 1962 by Gross and Lapiere, who found that tadpole tails 
during metamorphosis contained an enzyme that could degrade fibrillar collagen (Fig. 1) (Gross 
and Lapiere, 1962). Subsequently, an interstitial collagenase, collagenase-1 or MMP-1, was 
found in diseased skin and synovium. MMPs have been since identified as the major enzymes 
responsible for turnover of extracellular matrix (ECM) (Birkedal-Hansen et al., 1993). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.1. MMP structure and classification 
 
All MMPs share three main domains: a signal peptide, a propeptide and a catalytic domain. 
Additionally, some groups of MMPs can also have at their C-terminus the following domains: a 
hinge region, an hemopexin-like domain, a glycosylphosphatidylinositol (GPI) modification, a 
transmembrane domain or a cytosolic tail (Fig. 2).  
 
Based on the presence or absence of membrane anchoring domains, the MMP family 
members can be divided in two groups: secreted MMPs, which do not present membrane 
anchoring, and Membrane-Type MMPs (MT-MMPs), which are anchored to the membrane.  
 
These MT-MMPs can further be subdivided in two groups: 
 
1. GPI-anchored MT-MMPs: which bind to the membrane through a GPI modification. 
These proteins include MT4-MMP (MMP-17) and MT6-MMP (MMP-25). 
Figure 1: Photograph of culture of tadpole fin skin illustrating 
area of lysis around the explant. Remaining collagen gel 
substrate is seen as surrounding opalescent region within ring 
(magnification 9 X) (Taken from(Gross and Lapiere, 1962). 
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2. The transmembrane MT-MMPs: which are type I proteinases with a short cytosolic tail. 
This subfamily is formed of: MT1-MMP (MMP-14), MT2-MMP (MMP-15), MT3-MMP 
(MMP-16) and MT5-MMP (MMP-24).  
 
Another MT-MMP protein called MMP-23 has been described. This protein exists as a 
type II transmembrane protein (N-terminus inside the cell) or as a secreted form if it is 
cleaved (Velasco et al., 1999). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As mentioned, mammalian MMPs share a conserved domain structure that consists of an 
autoinhibitory propeptide and a catalytic domain. The propeptide is formed of about 80 amino 
acids and contains a conserved cysteine residue that coordinates the active-site zinc to inhibit 
catalysis. When the propeptide is destabilized or removed, the active site becomes available to 
cleave substrates.  
 
The catalytic domain comprises about 167-170 residues. Its active site is a 2 nm groove that 
runs across the catalytic domain. The zinc atom is located in this active site and it is bound to 
three histidine residues.  
 
All MT-MMPs and some soluble ones have a furin recognition motif inserted between the 
propeptide and the catalytic domain. This motif contains the basic sequence Arginine108-
Arginine109-Lysine110-Arginine111 that is recognized and cleaved by convertases like furin (Pei 
and Weiss, 1996). These convertases are calcium-dependent transmembrane serine proteinases 
of the subtilisin family and are prominently displayed in the trans Golgi network (Steiner et al., 
1998). It is there, in the Golgi network, where the propeptide is released from the catalytic domain 
Figure 2: Structural MMP classification based on the organization of their 
domains (Taken from(Folgueras et al., 2004). 
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by its cleavage between the Arginine111-Tyrosine112 (Rozanov et al., 2002a; Yana and Weiss, 
2000). 
 
Most MMP family members also contain an hemopexin-like domain attached at the C-
terminus of their catalytic domain by a flexible hinge region. The hemopexin-like domain is 
formed of about 200 residues and encodes a four-bladed β-propeller structure that resembles 
hemopexin (an heme binding serum protein). This domain has been described to have a role in 
many functions: matrix binding, substrate specificity recognition, protein-protein interactions, 
activation of the enzyme, proteinase localization, internalization and degradation (Page-McCaw et 
al., 2007). For example, the hemopexin-like domain plays a functional role in MMP binding to 
tissue inhibitors of metalloproteinases (TIMPs), a family of specific MMP protein inhibitors (Borden 
and Heller, 1997). In the case of MT-MMPs it has been observed that hemopexin domain of MT1-
MMP affects its collagenolytic activity by its binding to tetraspanin CD151 (Yanez-Mo et al., 2008) 
and moreover, it is essential for MT1-MMP induced cell migration (Cao et al., 2004).  
 
After the hemopexin repeats, which usually mark the end of the protein in most MMPs, all MT-
MMPs contain a C-terminal hydrophobic extension rich in hydrophobic residues involved in the 
attachment of these proteinases to the cell surface (Cao et al., 1995). As mentioned, MT4- and 
MT6-MMP have a GPI modification, a short hydrophobic domain that binds to the membrane in 
a non-permanent manner through a GPI bridge (Itoh et al., 1999; Kojima et al., 2000). 
 
By contrast, MT1-, MT2-, MT3- and MT5-MMP contain a long stretch of hydrophobic residues 
that are predicted to act as a transmembrane anchor in all of them. This sequence is followed 
by a cytosolic tail whose functional importance in different contexts has been addressed by 
several independent studies (Jiang et al., 2001; Lohi et al., 2000; Uekita et al., 2001). The aim of 
this work is to analyze the interactions of the cytoplasmic domain of the MT-MMPs with different 
proteins. The details of this domain will be explained later in the introduction.  
 
1.2. MMP regulation   
 
MMPs are regulated at different levels: gene expression, posttranslational modifications, 
proenzyme activation, inhibition, complex formation and compartmentalization. 
 
Induction of MMP gene expression is controlled by different growth factors and cytokines, 
and may be suppressed by transforming growth factor β and glucocorticoids (Nagase and 
Woessner, 1999). Moreover, an important modulatory role of epigenetic processes in the 
expression of MMPs has been described (Chernov et al., 2009). Besides soluble factors, MMP 
expression may also be regulated by cell–cell contact or interaction of cells with ECM 
components such as extracellular matrix metalloproteinase inducer (EMMPRIN) (Biswas et al., 
1995).  
 
MMPs can also have postranslational modifications than can regulate their activity. MT1-
MMP can be palmitoylated and phosphorylated at different sites and that these modifications can 
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influence MT1-MMP internalization or cell migration (Anilkumar et al., 2005; Moss et al., 2009; 
Nyalendo et al., 2007). This point will be explained in more detail later in the introduction. 
 
The expressed MMPs are secreted as inactive proenzymes with the propeptide effectively 
limiting entrance into and catalysis of a substrate in the catalytic pocket by blocking the catalytic 
zinc ion via the cysteine switch mechanism. ProMMP activation can occur through several 
mechanisms, all of which lead to disruption of the cysteine switch. For MT-MMPs, removal of the 
prodomain by convertases like furin has been described (Stawowy et al., 2005). Alternatively, the 
prodomain can be proteolytically removed by plasmin and other serine proteases, or even other 
MMPs (reviewed in(Ra and Parks, 2007). 
 
MMPs can also be regulated by specific inhibitors. An important family of MMP inhibitors is 
the TIMPs. Currently four TIMPs have been identified: TIMP-1, -2, -3 and -4. TIMP-1, -2 and -4 
are secreted in soluble form, whereas TIMP-3 is associated with the ECM (Westermarck and 
Kahari, 1999). TIMPs act to inhibit MMP activity by forming complexes with them. MT-MMPs 
exhibit differential inhibition by members of TIMP family; transmembrane MT-MMPs are poorly 
inhibited by TIMP-1, but they are relatively well inhibited by TIMP-2, TIMP-3 and TIMP-4. On the 
other hand, the GPI anchored MT-MMPs are inhibited by TIMP-1 and TIMP-2 (Seiki, 1999). In 
addition, MMPs can be also inactivated by other proteins such as the plasma membrane α2 
macroglobulin (Baker et al., 2002).  
 
MMP complex formation constitutes another mechanism of MMP regulation. For example, 
proMMP-9 monomer is more rapidly activated by MMP-3 than proMMP-9 homodimer (Olson et 
al., 2000). Another example of MMP activity regulation by its homodimerization is MT1-MMP 
(Galvez et al., 2005). Moreover, complex formation of MMPs with other proteins can also regulate 
their activity. For instance, when proMMP-9 forms a dimer with collagenase, binding to TIMP-1 is 
prevented (Strongin et al., 1993). 
 
Compartmentalization also regulates MMP activity by locating and concentrating them close 
to potential substrates. For example, intracellular association of MMP-1 with mitochondria and 
nucleus has implications for the control of cell growth, and may contribute to the association of 
this enzyme with tumor cell survival and spreading (Boire et al., 2005; Yang et al., 2009). Another 
example is the storage of MMPs in intracellular vesicles. Polymorphonuclear leukocytes and mast 
cells can store MMPs, as well as other proteinases, in exocytic vesicles and release them into the 
extracellular environment upon activation of the cells. Moreover, it has also been seen that 
endothelial cells, chondrocytes and various cancer cells can store MMPs in intracellular vesicles 
(Hadler-Olsen et al., 2011).  
 
1.3. MMP functions 
  
Historically, MMPs were thought to function mainly as enzymes that degrade structural 
components of the ECM. However, MMP proteolysis can have different functions: it can create 
space for cells to migrate, can produce specific substrate-cleavage fragments with independent 
biological activity, can regulate tissue architecture through effects on the ECM and intercellular 
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junctions, and can activate, deactivate or modify the activity of signaling molecules, both directly 
and indirectly (Fig. 3) (Sternlicht and Werb, 2001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Possible modes of MMP action (Taken from(Page-McCaw et al., 2007). A) MMPs can cleave 
components of the ECM, resulting in increased space for cell or tissue movement. B) Alternatively, MMP 
proteolysis can generate specific cleavage products that then signal in an autocrine or paracrine manner 
(for example, cleavage of collagen IV α3 chain by MMP-9 yields tumstatin, an anti-angiogenic peptide that 
functions by binding to the αvβ3 integrin (Hamano et al., 2003). C) MMPs can also directly regulate 
epithelial tissue architecture through cleavage of intercellular junctions or the basement membrane. D) 
MMPs can activate or modify the action of latent signaling molecules, resulting in diverse cellular 
consequences. For example, cleavage of vascular endothelial growth factor (VEGF) by MMPs changes 
angiogenic outcome by modifying the binding and diffusion properties of VEGF (Lee et al., 2005). E) MMPs 
can deactivate or modify the action of active signaling molecules, resulting in changes in proliferation, cell 
death, differentiation or cell motility. For example, MMP-2 cleavage of stromal-cell derived factor-1 (SDF1) 
results in its inactivation (McQuibban et al., 2001). 
 A 
 B 
      C 
 D 
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This diverse MMP activity leads to different MMP functions in development, which can be 
dissected by the analysis of MMP knockout mice. Studies of single-MMP-mutant mice have 
shown that MMPs are not essential for embryonic development but have a key role in 
postdevelopmental remodelling. In this sense MMP have been seen to be involved in the 
development of the mammary gland, skeleton and vascular system, three prominent sites of 
postnatal tissue ECM remodelling (Page-McCaw et al., 2007). 
 
MMP-2 and MMP-3 have been seen to be involved in postnatal mammary development. 
The epithelial ductal network of the mammary gland expands during puberty. This process 
requires degradation of the basement membrane and ECM, restructuring of endogenous vascular 
network and large-scale epithelial morphogenesis. It has been described that these two 
metalloproteinases are involved in branching morphogenesis in the mammary gland, participating 
in terminal end bud elongation and secondary branching (Wiseman et al., 2003).  
 
Several MMP knockout mice present bone remodelling defects. Deletion of MMP-9 (Vu et 
al., 1998) or MMP-13 (Stickens et al., 2004) results in expansion of the zone of hypertrophic 
chondrocytes in the growth plate because of a failure of apoptosis, indicating that these MMPs 
are required for the transition from cartilage to bone at the growth plates of long bones. MT1-MMP 
also plays a role in skeletal development (Holmbeck et al., 1999; Zhou et al., 2000). Interestingly, 
human skeletal diseases have been seen to be associated with MMP-2, MMP-13 or MMP-20 
loss-of-function MMP mutations (Kennedy et al., 2005; Kim et al., 2005; Martignetti et al., 2001).  
 
MMP-9-mutant mice show defects in angiogenesis at the growth plates of long bones (Vu et 
al., 1998). Similarly, MT1-MMP mutant mice lack appropriate vascular invasion at secondary 
ossification centres. The reduced irrigation of these areas due to the defects in vascular 
development is also related with the mentioned bone remodelling defects of these mice (Zhou et 
al., 2000).  
 
Moreover, the role of MMPs is not limited to developmental processes. Mouse-mutant 
experiments show that MMPs are also required to maintain homeostasis in response to 
environmental challenges, such as infection. In this regard it has been described that MMP-7 is 
involved in innate immunity. Studies with MMP-7 knockout mice showed that they were more 
easily infected with intestinal bacteria due to their inability to proteolytically activate an 
endogenous antibiotic peptide, pro-cryptdin (Wilson et al., 1999). Inflammation is another 
response that requires MMPs. For example, recruitment of inflammatory cells to alveoli following 
lung injury is defective in MMP-7 deficient mice due to impaired shedding release of chemokines. 
Finally, MMPs are related with cancer. Tumor cells are believed to use their pericellular 
degrading activity to spread to distant sites (John and Tuszynski, 2001). Moreover, MMPs also 
promote tumor angiogenesis (Deryugina et al., 2002). In humans high levels of MMPs in tumors 
often correlate with poor prognosis. However, the relationship between MMPs and disease is not 
simple and increased MMP activity can enhance tumor progression or can inhibit it (Coussens et 
al., 2002). For example, studies with mutant mice deficient in MMP-8 demonstrated the in vivo 
anti-tumor properties of this proteinase; the absence of MMP-8 strongly increased the incidence 
of skin tumors in these animals (Balbin et al., 2003). 
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2. The transmembrane MT-MMPs 
 
      Observations derived from analysis of the structure, exon–intron organization, and 
chromosomal localization of MT-MMP genes, suggest that MT-MMPs diverged early in the 
evolutionary history of MMPs. A view of the evolutionary history of MT-MMPs can be obtained 
from the analysis of the presence of these proteinases in diverse organisms. MT-MMPs have 
been identified in many mammalian species, as well as in birds and in fish (Kimura et al., 2001; 
Yang et al., 1996). From comparative studies it has been observed that there is a strikingly 
increased complexity of the MT-MMP system in vertebrates, both in the number of proteins 
belonging to the family and in the domain structure and anchoring systems used by these 
enzymes for membrane binding. Presumably, this increased complexity of MT-MMPs in 
vertebrates is necessary to deal with a series of vertebrate innovations including those derived 
from the occurrence of more complex cell–cell and cell–matrix interactions in vertebrates, or from 
the prominent development of complex immunological, neural, and vascular systems in these 
organisms (Zucker et al., 2003). 
 
As explained previously, MT-MMP members can be anchored to the membrane though a GPI 
(MT4- and MT6-MMP) or by a transmembrane domain (MT1-, MT2-, MT3- and MT5-MMP). This 
second group is the focus of this work. In this section, general characteristics of each 
transmembrane metalloproteinase and the most important features of their cytosolic tails will be 
described.  
 
2.1. MT1-MMP 
 
2.1.1. General features    
 
MT1-MMP was discovered in 1994 and is by far the best characterized MT-MMP. It is 
ubiquitously expressed. It is formed of 583 amino acids and it has a molecular weight of 65kDa  
(Sato et al., 1994). 
 
MT1-MMP can be regulated by transcription factors, growth factors, cytokines, nitric oxide, 
cell-cell contact, ectodomain processing, ECM, compartmentalization and internalization (MT1-
MMP internalization is explained in the MT1-MMP cytosolic tail section).  
 
 Haas and coll. have characterized the murine MT1-MMP gene promoter establishing that 
there are consensus binding sites for transcription factors including early growth response   
protein 1 (EGR-1), adaptor protein 4 (AP-4) and nuclear factor kappa-light-chain-enhancer of 
activated B cells (NF-kB) but not stress response elements such as heat shock element (HSE) 
(Haas et al., 1999).  
 
Other molecules, such as growth factors and cytokines, are also involved in the regulation of 
MT1-MMP (Foda et al., 1996; Lohi et al., 1996; Yang et al., 1996). These include interleukin 1β 
(IL1β), tumor necrosis factor α (TNFα), basic fibroblast growth factor (bFGF), granulocyte-
macrophage colony-stimulating factor (GM-CSF) (Rajavashisth et al., 1999; Tomita et al., 2000), 
scatter factor/hepatocyte growth factor (SF/HGF) (Wang and Keiser, 2000), chemokine C-C motif 
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ligand 2 (CCL2) and interleukin 8 (IL-8) (Galvez et al., 2005). Moreover, our group has also 
identified MT1-MMP as a key molecular effector of nitric oxide, a critical modulator of 
angiogenesis (Genis et al., 2007).  
 
Cell-cell contact has also been reported to modulate MT1-MMP expression. MT1-MMP mRNA 
appears to decrease in cells following achievement of cell confluency (Tanaka et al., 1997). In this 
regard, it has been seen that transfection of E-cadherin cDNA into squamous carcinoma cells led 
to a decrease in MT1-MMP mRNA as well as decreased amounts of activated MMP-2 (Ara et al., 
2000).  
 
Proteolytic ectodomain processing of MT1-MMP on the cell surface also represents an 
important mechanism for regulating enzyme activity. Active MT1-MMP undergoes autocatalytic 
processing on the cell surface leading to the formation of an inactive 43/45 kD fragment remaining 
on the cell surface and the release of soluble catalytic domain fragments; both autocatalytic      
(18 kD) and non autocatalytic (56, 50, 31–35 kD) fragments have been identified (Toth et al., 
2002).  
 
MT1-MMP can be also regulated by the ECM. For example, it has been characterized that 
plating cells on fibronectin leads to MT1-MMP activation in fibrosarcoma cells without apparent 
change in MT1-MMP or TIMP-2 levels (Stanton et al., 1998). 
 
MT1-MMP compartmentalization is also a relevant mechanism for its regulation. 
Compartmentalization can be dependent on MT1-MMP association with other proteins such as 
CD44, which leads MT1-MMP to the leading edge (Mori et al., 2002). Other proteins that regulate 
MT1-MMP are integrins (reviewed in(Gonzalo et al., 2010b). MT1-MMP can be associated with 
αvβ3 integrin and caveolin-1 in EC membrane protrusions where MT1-MMP is active (Galvez et 
al., 2002; Galvez et al., 2004). Moreover, MT1-MMP can also associate with α3β1 integrin in 
tetraspanin(Tspan)-organized membrane microdomains (Yanez-Mo et al., 2009). Notably, the 
ternary complex constituted by MT1-MMP, α3β1integrin and Tspan CD151 at the junctions of 
human EC resulted in a reduced MT1-MMP proteolytic activity at these sites (Yanez-Mo et al., 
2008). 
 
The substrate specificity of MT1-MMP activity is well described in literature. This enzyme is 
capable of proteolytic degradation of type I, II and III collagen, and  many other ECM components, 
such as fibronectin, vitronectin, tenascin, nidogen, aggrecan, fibrin, fibrinogen and laminin-5 
(reviewed in(Barbolina and Stack, 2008).  
 
Apart from ECM components, MT1-MMP is capable of cleaving many membrane-anchored 
proteins such as E- and N-cadherin, integrins, CD44, receptor activator of NF-κB ligand (RANKL) 
and several cell surface proteoglycans and their receptors (Barbolina and Stack, 2008). MT1-
MMP also cleaves α3 and α5, but not α2, integrin chains. Ratnikov and coll. proposed that MT1-
MMP-mediated integrin processing in the same cell may be a general mechanism by which cells 
selectively regulate the functionality of integrins in promoting cell adhesion, migration, and focal 
adhesion kinase phosphorylation (Ratnikov et al., 2002). 
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Moreover, MT1-MMP can cleave other MMPs. MT1-MMP was originally identified as the 
extracellular proteinase responsible for activation of proMMP-2, and this process remains the 
best-described proteolytic function of the enzyme. In this process, one of the units of an MT1-
MMP dimer forms a trimeric complex with proMMP-2 and TIMP-2 at the cell surface, leading to 
proteolytic removal of the propeptide of the proMMP-2 by the ‘free’ MT1-MMP unit  (Cao et al., 
1996). Besides proMMP-2, also proMMP-13 (Knauper et al., 2002) and proMMP-8 (Holopainen et 
al., 2003) have been identified as possible targets for activation through this mechanism. 
 
Although the main proteolytic function of MT1-MMP lies in the cleavage of extracellular 
substrates, some studies indicate a role in intracellular proteolysis after incorporation and 
accumulation of active MT1-MMP in the centrosomal compartment, where it could contribute to 
development of mitotic spindle changes by degradation of pericentrin (Golubkov et al., 2005).  
 
      To define the in vivo function of MT1-MMP several groups have generated MT1-MMP 
deficient mice (Holmbeck et al., 1999; Sakamoto and Seiki, 2009; Zhou et al., 2000). These mice 
are the only lethal MMP-mutant mice due to their severe defects in skeletal development and 
angiogenesis that cause a marked deceleration of postnatal growth and death within 3–16 weeks.  
 
The main defect of MT1-MMP-deficient mice is in skeletal development. MT1-MMP mutants 
are grossly defective in remodelling of connective tissue. Loss of an ECM-degrading enzyme 
would be expected to result in increased bone deposition; paradoxically, MT1-MMP mutants 
instead show secondary effects of increased bone resorption and defective secondary ossification 
centres (Holmbeck et al., 1999; Zhou et al., 2000). These skeletal defects are also related with 
the defective vascular invasion of the cartilage observed in these mice. The defects in 
angiogenesis and vascular component of the MT1-MMP deficient mice may be due to the 
impairment or delay of different processes taking place in the absence of MT1-MMP. Our group 
has demonstrated that MT1-MMP is involved in migration of endothelial cells into the ECM 
(Galvez et al., 2001). Moreover, Robinet and coll. have described that the formation and 
stabilization of new formed capillary tubes may also be dependent on MT1-MMP activity (Robinet 
et al., 2005). MT1-MMP is also able to release vascular endothelial growth factor A (VEGF-A), 
again promoting neovascularisation (Sounni et al., 2004). Besides, it has been observed that 
postnatal angiogenesis in response to FGF-2 in MT1-MMP null mice is also markedly deficient in 
a corneal model (Zhou et al., 2000). Defects in angiogenesis also affect postnatal development of 
the alveolar septum, leading to lung secondary expansion failure (Oblander et al., 2005). Finally, 
MT1-MMP deficient mice present defects in myeloid cell fusion (Gonzalo et al., 2010a), in 
submandibular gland (Oblander et al., 2005), adipose tissue (Chun et al., 2006) and kidney 
development (Riggins et al., 2010). 
 
MT1-MMP also plays a role in pathology. There is clear evidence that MT1-MMP is involved 
at different stages of tumor progression from initial tumor development, growth and angiogenesis 
to invasion, metastasis and growth at secondary sites (Gilles et al., 1997; Seiki et al., 2003; 
Sounni et al., 2003; Zucker et al., 2003). Moreover, association between MT1-MMP expression 
and poor prognosis in cancer patients has been established for different cancer types such as 
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breast cancer (Vizoso et al., 2007), neuroblastoma (Sakakibara et al., 1999) or small cell lung 
cancer (Michael et al., 1999).  
 
2.1.2. MT1-MMP cytosolic tail                       
 
MT1-MMP cytosolic tail consists of 20 amino acids (RRHGTPRRLLYCQRSLLDKV) and it has 
been described to have a role in MT1-MMP localization, invasive activity, trafficking, signaling and 
dimerization. For some of these functions posttranslational modifications of cytosolic residues or 
cytosolic tail interacting partners have been identified (Table 1). 
 
Table 1: MT1-MMP cytosolic tail binding proteins.   
 
The first studies that analyzed the role of MT1-MMP cytosolic tail in MT1-MMP localization 
were performed by Nakahara and collaborators. They demonstrated that MT1-MMP required its 
cytoplasmic domain to localize to the invadopodia of tumor cells, protruding membrane structures 
associated with invasive cancer cells (Nakahara et al., 1997).  
 
Later, Lehti and coll. reported that MT1-MMP cytosolic tail was not only important for MT1-
MMP localization but also for its invasive activity. This group showed that, when the last 10 
amino acids of MT1-MMP were deleted, the invasive activity of human melanoma cells was 
reduced (Lehti et al., 2000). Moreover, it has been described that MT1-MMP cytosolic tail is not 
only important in tumor cell invasion but also plays a role in physiological contexts such as MT1-
MMP non-proteolytic activity to boost macrophage migration (Sakamoto and Seiki, 2009). Other 
studies have shown that when MT1-MMP is localized in these migrating cell domains, it interacts 
with signal-transducing intermediates such as cortactin (Artym et al., 2006) or the focal adhesion 
protein p130Crk-associated substrate (CAS) (Gingras et al., 2008; Gonzalo et al., 2010a).  
Moreover, Uekita and coll. saw that the cytosolic tail of MT1-MMP can bind to MTCBP-1, a 
member of cupin superfamily, and both colocalized at the adherent membrane edge. This group 
also saw that an enforced expression of MTCBP-1 could inhibit the activity of MT1-MMP in cell 
migration and invasion promotion (Uekita et al., 2004). Finally, it has been seen that tyrosine 573 
and threonine 567 of MT1-MMP cytosolic tail can be phosphorylated and that these modifications 
influence cell migration and invasion (Moss et al., 2009; Nyalendo et al., 2007).  
 
Cytosolic tail 
interacting 
proteins 
Function Reference 
Cortactin 
p130Cas 
MTCBP-1 
MT1-MMP 
AP-2 complex 
P-caveolin 1 
Abl kinases 
Tubulin 
p59 
gC1qR 
Radixin 
Cell migration 
Cell migration and fusion 
Cell migration 
MT1-MMP activity 
MT1-MMP endocytosis 
MT1-MMP endocytosis and Src regulation 
MT1-MMP endocytosis 
MT1-MMP endocytosis 
Intracellular MT1-MMP trafficking 
Intracellular MT1-MMP trafficking 
Unknown 
(Artym et al., 2006) 
(Gingras et al., 2008; Gonzalo et al., 2010a) 
(Uekita et al., 2004) 
(Kazes et al., 2000; Rozanov et al., 2001) 
(Uekita et al., 2001) 
(Labrecque et al., 2004) 
(Smith-Pearson et al., 2010) 
(Radichev et al., 2009) 
(Kuo et al., 2000) 
(Rozanov et al., 2002b) 
(Terawaki et al., 2008) 
Introduction 
 21
In contrast to the results pointing to a role of MT1-MMP cytosolic tail in migration and 
invasion, Rozanov and coll. saw that, although the cytosolic tail was involved in invasion of MCF7 
breast carcinoma cells, when using the extremely migratory U-251 glioma cells, MT1-MMP 
cytosolic tail did not affect cell locomotion (Rozanov et al., 2001). Moreover, Hotary and coll. were 
unable to detect MT1-MMP cytosolic tail function in COS or MDCK cell invasion of basement 
membranes or collagen gels (Hotary et al., 2000; Hotary et al., 2006). Thus, it seems probable 
that the discrepancy obtained in this issue can be attributed to the different cellular assays used 
to address this question. 
 
Homophilic complex formation of MT1-MMP on the cell surface has been demonstrated. This 
mechanism fits the requirement for two adjacent MT1-MMP molecules cooperating to cleave one 
proMMP-2 molecule. Moreover, it was observed that MT1-MMP dimerization positively regulates 
its activity (Galvez et al., 2005). A cysteine residue (C574) present in the cytosolic tail of MT1-
MMP is apparently involved in an intermolecular disulfide bond linking monomers of this 
proteinase and generating stable covalent dimers of MT1-MMP on the cell surface (Kazes et al., 
2000; Rozanov et al., 2001). In contrast, Itoh and coll. proposed that the hemopexin like domain 
of MT1-MMP was the responsible for homophilic complex formation (Itoh et al., 2001). However, 
Overall and coll. were unable to detect homodimer formation of MT1-MMP hemopexin domains 
(Overall et al., 2000). Later, Lehti and coll. concluded that both the hemopexin-like and 
cytoplasmic domains of MT1-MMP were involved in the formation of enzyme oligomers that 
function in intermolecular proteolytic events at the cell surface (Lehti et al., 2002).  
 
The redistribution of MT1-MMP to the sites of ECM degradation to promote migration involves 
a dynamic interplay of exocytic (Bravo-Cordero et al., 2007) and endocytic (Jiang et al., 2001; 
Uekita et al., 2001) trafficking events. MT1-MMP cytosolic tail has a role in its exocytic 
trafficking to discrete regions of the cell surface. In this sense, it has been shown that MT1-MMP 
C-terminus mutants accumulate in an early exocytic compartment and do not reach the Golgi 
compartment. Moreover, for the correct trafficking of MT1-MMP to the cell membrane the last 
valine of its cytosolic tail is critical (Urena et al., 1999).  
 
The cytoplasmic domain of MT1-MMP also plays an important role in the regulation of its 
internalization (Jiang et al., 2001; Lehti et al., 2000; Nakahara et al., 1997; Uekita et al., 2001). 
Endocytosis of MT1-MMP occurs primarily through clathrin-dependent mechanisms (Jiang et al., 
2001; Remacle et al., 2003). MT1-MMP is palmitoylated at Cys574 and this modification is critical 
for its promotion of clathrin-mediated internalization (Anilkumar et al., 2005). Moreover, the 
efficient endocytosis of MT1-MMP is related, at least in part, to its interaction with the μ2 subunit 
of adaptor protein 2 (AP-2), a key component of clathrin-coated vesicles (Uekita et al., 2001).   
 
In addition to MT1-MMP endocytosis through clathrin-dependent mechanisms (Jiang et al., 
2001; Remacle et al., 2003), a significant proportion of the enzyme is associated with caveolae 
(Annabi et al., 2001; Galvez et al., 2004; Labrecque et al., 2004; Remacle et al., 2003). In this 
regard, it has been seen that overexpression of the cytosolic tail-deleted form of MT1-MMP 
resulted in an increased association of this mutant with caveolae that correlates with impaired 
internalization and reduced cell migration in vitro and tumor growth in vivo (Rozanov et al., 2004). 
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Since endocytosis via caveolae is dependent on phosphorylation of caveolin-1 at Tyr14 and MT1-
MMP specifically interacts with tyrosine phosphorylated caveolin-1 (Labrecque et al., 2004), it is 
probable that this interaction could thus participate in regulating caveolae-mediated internalization 
of the enzyme. Interestingly, the association of MT1-MMP with phosphorylated caveolin-1 has 
been seen to induce the recruitment of Src, the kinase responsible of caveolin phosphorylation, 
and a concomitant inhibition of the kinase activity of the enzyme, suggesting that this complex 
may be involved in the negative regulation of Src activity (Labrecque et al., 2004). 
 
Another MT1-MMP cytosolic partner involved in its internalization process was described by 
Smith-Pearson and coll. They showed that active Abl kinases form complexes with MT1-MMP 
and that loss of Abl kinase signaling induced internalization of MT1-MMP from the cell surface 
and promoted its accumulation in the perinuclear compartment (Smith-Pearson et al., 2010). 
Regarding intracellular trafficking, two more proteins have been seen to interact with MT1-MMP 
cytosolic tail and being involved in its intracellular trafficking: the Golgi protein p59 (Kuo et al., 
2000) and gC1qR, a chaperone-like compartment-specific regulator (Rozanov et al., 2002b). 
 
Additionally, the cytosolic tail of MT1-MMP is involved in MT1-MMP recycling. Wang and coll. 
showed that the deletion of the last three residues (DKV) of the cytosolic tail of MT1-MMP 
significantly impaired its recycling after an apparently normal internalization process (Wang et al., 
2004b).  
 
      Finally, MT1-MMP cytosolic tail can also regulate intracellular signaling pathways. MT1-MMP 
can contribute to cell proliferation by its activation, through the tyrosine-protein kinase Src, of focal 
adhesion kinase (FAK) and extracellular signal-regulated kinase (ERK) (Takino et al., 2010). 
Moreover, Deryugina and coll. observed that overexpression of MT1-MMP in tumor cells up-
regulated VEGF production, increasing the endothelial cell response and subsequent tumor 
vascularisation and growth (Deryugina et al., 2002). 
 
To conclude, it is important to highlight the systematic whole-cell analysis of MT1-MMP-
associating proteins carried out by Dr. Seiki´s laboratory in which they identify numerous 
candidate proteins to interact directly or indirectly with MT1-MMP. Interaction of MT1-MMP 
cytosolic tail with some cytosolic proteins and membrane proteins identified in these studies is 
expected. However, no further analyses in this sense were performed (Niiya et al., 2009; Tomari 
et al., 2009). 
 
2.2. MT2-MMP    
 
2.2.1. General features 
 
MT2-MMP was first described in 1995 as the second member of the MT-MMP subfamily. It is 
formed of 670 amino acids and it has a molecular weight of 75 kD. Although it is a ubiquitously 
expressed enzyme (Takino et al., 1995), some studies have pointed to a higher expression in 
epithelial cells. Plaisier and coll., by analyzing the expression of MT2-MMP in endometrial cells in 
vitro, observed that MT2-MMP was much more expressed in human endometrial epithelial cells 
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than in endothelial ones (Plaisier et al., 2006). In submandibular gland this cell type specific 
expression has also been observed; MT2-MMP is predominantly expressed in the epithelium and 
little expression in mesenchyme is detected (Rebustini et al., 2009). 
 
About MT2-MMP regulation, it has been described that TNFα increases its expression in 
cultured human retinal epithelial cells (Eichler et al., 2002) and trophoblasts (Hiden et al., 2007).   
 
Regarding MT2-MMP activity this metalloproteinase can degrade gelatin, laminin and fibrin 
(Hotary et al., 2002). Moreover, MT2-MMP is also capable of activating MMP-2 proenzyme in a 
mechanism not dependent on the presence of TIMP-2 (Morrison et al., 2001; Morrison and 
Overall, 2006). 
 
Several MT2-MMP functions have been described. Lafleur and coll. determined that MT2-
MMP affects the formation of capillary-like tubes in vitro, indicating a possible role of MT2-MMP in 
angiogenesis (Lafleur et al., 2002). Additionally, MT2-MMP plays a role in submandibular gland 
development; downregulation of MT2-MMP in explant cultures produces an impaired 
submandibular gland branching morphogenesis due to disruption of collagen IV metabolism and 
reduction of cell proliferation (Rebustini et al., 2009). Moreover, antiapoptotic properties of MT2-
MMP have been described (Abraham et al., 2005). Finally, it has been observed that MT2-MMP 
plays a role in follicle rupture during ovulation (Ogiwara et al., 2005).  
 
In vitro studies have shown a role of MT2-MMP in invasion. It has been observed that COS 
cells expressing MT2-MMP acquire the ability to perforate and transmigrate through peritoneal 
membrane, epithelial basement membranes (Hotary et al., 2006) and collagen I gels (Hotary et 
al., 2000). However, when MT2-MMP MDCK transfectants were used different results were 
obtained. When these cells where plated on top of peritoneum high invasion was detected. But, 
on the contrary, MT2-MMP MDCK transfectants did not show nearly any invasive activity in a 
collagen I gel system. Instead, MT2-MMP-overexpressing cells formed a disorganized 
multilayered structure on top the collagen matrix (Hotary et al., 2000). These differences, in 
authors opinion, may indicate that COS cells regulate MT2-MMP in a more balanced fashion than 
MDCK and/or that MT2-MMP MDCK transfectants penetrate the peritoneum by degrading 
extracellular matrix components other than type I collagen (Hotary et al., 2000).  
 
Despite of these functions, reported MT2-MMP knockout mice do not show defects in 
development or in postnatal growth. Moreover, these mice have mendelian ratios and neither 
female nor male mice display any significant difference in body-weight compared with wild-type 
littermates. Consistenty, mice likewise display no overt aberration in size and general 
appearance. Moreover, the lifespan, behaviour and grooming habits are normal and MT2-MMP- 
deficient mice reproduce normally. However, the combined loss of MT1- and MT2-MMP produces 
a major impact in mice development and leads to arrest of gestation at embryonic day 10.5. This 
arrest appeared to be due to the inability of trophoblasts to form the syncitya required for the 
development of a functional placental labyrinth (Szabova et al., 2010). 
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Involvement of MT2-MMP in pathology is still unclear. It has been seen that MT2-MMP is 
present in different types of tumors, such as glioblastoma (Zhang et al., 2005), non-small cell lung 
carcinoma (Atkinson et al., 2007), ovarian (Davidson et al., 2001) and breast carcinoma (Ueno et 
al., 1997), and seems to correlate with tumor invasiveness (Zhang et al., 2005). Moreover, a MT2-
MMP role in tumor angiogenesis has also been reported (Chen et al., 2010). 
 2.2.2. MT2-MMP cytosolic tail 
     MT2-MMP cytosolic tail consists of 20 amino acids (QRKGAPRVLLYCKRSLQEWV). No roles 
or interacting proteins of MT2-MMP cytoplasmic domain have been described to date. 
 
2.3. MT3-MMP 
 
2.3.1. General features 
 
MT3-MMP was first described in 1997 (Matsumoto et al., 1997) but is still poorly described in 
literature. MT3-MMP is formed of 608 amino acids and presents a molecular weight of 69 kD. The 
crystal structure of MT3-MMP has been elucidated and shows extensive similarity to MT1-MMP 
(Lang et al., 2004). Its expression has been analyzed in mice where it has been found in brain, 
kidney, heart, lung and testis. It is also expressed in mesenchymal tissues of the skeleton and in 
peri-skeletal soft connective tissue (Nuttall et al., 2004). 
 
Although MT3-MMP is a transmembrane metalloproteinase, homology screening for human 
MT-MMPs has resulted in the identification of a minor cDNA encoding a soluble type of MT3-
MMP lacking the transmembrane domain that is considered to be an alternatively spliced variant 
of MT3-MMP (Shofuda et al., 1997). Soluble MT3-MMP has the same proteolytic effect on 
extracellular matrix substrates and proMMP-2 as native MT3-MMP (Matsumoto et al., 1997). 
 
MT3-MMP can be regulated at different levels. Expression of MT3-MMP mRNA is strongly 
increased by platelet-derived growth factor (PDGF) and fibronectin (Shofuda et al., 1998). 
Moreover, HGF has been shown to stimulate MT3-MMP activity (Kang et al., 2000). MT3-MMP is 
also regulated by its recycling which occurs together with MT1-MMP. Both proteins are 
transported to trans-Golgi by early endosomes and driven together again to the cell surface 
(Wang et al., 2004b). Finally, was observed that MT3-MMP is rapidly degraded after maturation in 
COS-7 transfected cells (Shofuda et al., 1997). 
 
Regarding MT3-MMP activity, this metalloproteinase is able to degrade fibronectin, type I 
and type III collagen and activate proMMP-2, by a TIMP-2-dependent mechanism, and    
proMMP-13 (Zhao et al., 2004).  
 
Relating MT3-MMP function a role in invasion has been described.  It has been observed 
that COS cells expressing MT3-MMP acquire the ability to transmigrate peritoneal or epithelial 
basement membranes. Moreover, siRNA-mediated silencing of MT3-MMP in MDA-MB-231 cells 
decreases their ability to perforate and invade basement membranes (Hotary et al., 2006). On the 
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contrary, it has been recently found that MT3-MMP can reduce melanoma cell collagen invasion 
(Tatti et al., 2011). Furthermore, Kang and coll. have shown that MT3-MMP has potential to 
directly enhance the growth of MDCK cells (Kang et al., 2000). In addition, it has been shown that 
capillary-like tube formation by human endometrial microvascular endothelial cells is mediated by 
MT3-MMP, suggesting that MT3-MMP may be a potential regulator of endometrial angiogenesis 
(Plaisier et al., 2004). MT3-MMP can also regulate neuronal responsiveness to myelin though its 
cleavage of Nogo-66 receptor 1 (Ferraro et al., 2011). 
 
As mentioned, MT3-MMP is expressed in mesenchymal tissues of the skeleton and in peri-
skeletal soft connective tissue. Moreover, MT3-MMP works as a major collagenolytic enzyme, 
enabling cartilage and bone cells to cleave high-density fibrillar collagen and modulate their 
resident matrix to make it permissive for proliferation and migration (Shi et al., 2008). Consistent 
with this, MT3-MMP deficient mice display growth inhibition tied to a decreased viability of 
mesenchymal cells in skeletal tissues and deficiencies in bone formation in the cranium and long 
bones. These results indicate that MT3-MMP is required for extracellular matrix remodelling (Shi 
et al., 2008). 
 
As the deficit in proteolytic capacity of MT3-MMP knockout mice may be offset, at least 
partially through the activity of close related enzymes like MT1-MMP, Shi and coll. generated 
MT1-MMP/MT3-MMP double-deficient mice (Shi et al., 2008). In this case, the mice were born 
with severe developmental defects in collagen-rich tissues, including a severe dysfunction in 
palatal shelf formation leading to cleft palate that caused the demise of mice shortly after birth.  
 
Finally, regarding MT3-MMP implication in pathologies it has been described that it plays a 
role in the invasiveness of malignant tumor tissues such as renal carcinoma (Kitagawa et al., 
1999) or melanoma (Jaeger et al., 2007).  
 
2.3.2. MT3-MMP cytosolic tail 
 
      MT3-MMP cytosolic tail consists of 20 amino acids (KRKGTPRHILYCKRSMQEWV). No roles 
or interacting proteins of MT3-MMP cytoplasmic domain have been described to date, although a 
role in recycling due to its similarities and co-recycling with MT1-MMP could be expected (Wang 
et al., 2004b). 
 
2.4. MT5-MMP    
 
2.4.1. General features 
 
MT5-MMP was first described in 1999 and it is expressed predominantly in brain, and at low 
levels in kidney, pancreas and lung (Llano et al., 1999). MT5-MMP structural domains follow the 
general structure of the other MT-MMPs. However, it contains two small segments with divergent 
sequences: the hinge and the stem region with two dibasic motifs that can be potentially 
recognized by convertases. Through this mechanism MT5-MMP tends to be shed from the cell 
surface as a soluble enzyme (Pei, 1999). This characteristic appears to be unique to MT5-MMP 
since others MT-MMPs lack such a cryptic furin motif in the analogous positions. 
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Regarding MT5-MMP regulation, very little is known. Wang and coll. have determined that 
MT5-MMP can be regulated by its recycling to the cell surface through its interaction with Mint-3 
(Wang et al., 2004a). 
 
About MT5-MMP activity, it has been shown to degrade several ECM components, such as 
fibronectin, gelatin or inhibitory chondroitin sulphate proteoglycans (Hayashita-Kinoh et al., 2001). 
Moreover, MT5-MMP appears capable of mediating the cleavage of cell-adhesion molecules such 
as N-cadherin (Monea et al., 2006). However, the best established function for MT5-MMP is its 
ability to activate proMMP-2 (Pei, 1999).  
 
To analyze MT5-MMP functions two strains of MT5-MMP knockout mice have been 
generated. The first one was generated by Komori and coll. (Komori et al., 2004). This group 
observed that MT5-MMP-deficient mice were born without obvious morphological abnormalities 
and no apparent histological defects in the nervous system. Then, they examined the effect of 
MT5-MMP deficiency on the development of a severe, long-lasting neuropathic pain caused by 
lesions in the nervous system. One characteristic feature of neuropathic pain is mechanical 
allodynia, which is defined as pain evoked by non-noxious mechanical stimuli. They observed that 
MT5-MMP deficient mice did not develop neuropathic pain with mechanical allodynia after sciatic 
nerve injury, though responses to acute noxious stimuli were normal (Komori et al., 2004; Woolf 
and Mannion, 1999). 
 
Later, Folgueras and coll. generated another strain of MT5-MMP deficient mice (Folgueras et 
al., 2009). In their studies, they described that MT5-MMP plays an important role in cell-cell 
interactions between nociceptive neurites (neurites from a sensory neuron) and mast cells. Their 
data demonstrated that the absence of MT5-MMP leads to a phenotype of hyperinnervation and 
enhanced sensitivity to noxious thermal stimuli in MT5-MMP knockout mice. Their results also 
indicated that mast cell degranulation requires physical cell-cell interaction with sensory neurites 
and that MT5-MMP regulates this interaction by a mechanism involving N-cadherin (Folgueras et 
al., 2009).  
 
Moreover, the expression of MT5-MMP has been related with pathology as it has been 
detected in various cancer cells and tissues, most importantly in aggressive brain tumors (Llano 
et al., 1999). 
 
2.4.2. MT5-MMP cytosolic tail 
 
MT5-MMP cytosolic tail consists of 20 amino acids (KNKTGPQPVTYYKRPVQEWV) and has 
been seen to play a role in several MT5-MMP functions. For some of these functions, MT5-MMP 
cytosolic tail interacting proteins have been described (Table 2).  
 
As previously mentioned, Wang and coll. determined that MT5-MMP cytosolic tail is involved 
in its recycling to the cell surface by its interaction with Mint-3 in the trans-Golgi network. 
Moreover, they concluded that Mint-3 binds to the PDZ (Post-Synaptic Density 95 kD protein/ 
Drosophila melanogaster Discs Large protein/ Zonula Occludens 1) binding motif, EWV, of MT5-
MMP cytosolic tail (Wang et al., 2004a). 
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Table 2: MT5-MMP cytosolic tail binding proteins. 
 
 
MT5-MMP has also been reported to bind to glutamate receptor interaction protein (GRIP) 
and AMPA receptor binding protein (ABP), two related PDZ domain proteins that target AMPA 
receptors to synapses (Monea et al., 2006). Characterization of MT5-MMP and ABP interaction 
showed that ABP PDZ5 was the binding site for MT5-MMP (Feng et al., 2003). Moreover, Monea 
and coll. described that deletion of the PDZ binding motif of MT5-MMP impaired its membrane 
trafficking to filopodia tips of growth cones in cultured embryonic hippocampal neurons and to 
synapses in mature neurons (Monea et al., 2006). Taking all these data together, they concluded 
that ABP could be leading MT5-MMP proteolytic activity to growth cones and synaptic sites in 
neurons, where it might be regulating axon path finding or synapse remodelling (Monea et al., 
2006). 
 
2.5. Comparative analysis of MT1-, MT2-, MT3- and MT5-MMP 
 
2.5.1. Specificity versus redundancy  
 
      In this section reported similarities versus differences of transmembrane MT-MMPs will be 
discussed, highlighting their possible redundancy and specificity.  
 
      To dissect transmembrane MT-MMP functions, mouse mutants of each MT-MMP have been 
generated. All of these knockout mice can survive to birth and only show, with the exception of 
MT1-MMP, subtle phenotypes. Possible explanations for the dispensability of the transmembrane 
MT-MMPs during embryonic development are enzymatic redundancy and enzymatic 
compensation. These MT-MMPs have many overlapping substrates in vitro, such as gelatin or 
fibronectin, which indicates a possible redundancy in vivo (Page-McCaw et al., 2007). Indeed, 
redundancy has been determined with the generation of MT-MMP double mutants. MT2-MMP 
deficient mice do not show any apparent defects. However, when both MT1- and MT2-MMP are 
not expressed, mice die during the embryonic development (Szabova et al., 2010). Similar results 
have been obtained in the case of MT3-MMP. MT3-MMP knockout mice show growth inhibition 
due to deficiencies in bone formation; but in MT1-MMP/MT3-MMP double-deficient mice these 
bone formation deficiencies are aggravated, leading to demise of mice shortly after birth (Shi et 
al., 2008). 
 
      Enzymatic compensation between transmembrane MT-MMPs has also been found. For 
example, fibroblasts that lack MT1-MMP and show a defect in fibrin gel invasion are able to 
overcome this defect by MT2- or MT3-MMP compensation (Hotary et al., 2002). Another example 
has been shown by Rebustini and coll., who observed a coordinated transcription regulation of 
Cytosolic tail interacting proteins Function Reference 
Mint-3   
 
AMPA receptor Binding Protein (ABP) 
 
 
Glutamate Receptor Interacting 
Protein (GRIP) 
MT5-MMP recycling 
 
Possible role in  axon path finding or 
synapse remodelling 
 
Unknown 
(Wang et al., 2004a) 
 
(Monea et al., 2006) 
 
 
(Monea et al., 2006) 
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MT-MMPs in submandibular gland. They saw that reducing MT1- or MT3-MMP expression 
upregulated MT2-MMP, while reducing MT2-MMP expression upregulated MT3-MMP expression. 
In concordance, they also observed that in the submandibular gland of MT1-MMP knockout mice 
MT2-MMP was highly upregulated (Rebustini et al., 2009). 
 
      Enzymatic regulation between MT-MMPs has been recently reported. Tatti and coll. have 
observed that MT3-MMP can affect MT1-MMP localization and its promotion of invasion in 
melanoma cells. Coimmunoprecipitation of these proteins and induced processing of MT1-MMP 
by MT3-MMP have been also described (Tatti et al., 2011). 
 
      Nevertheless, transmembrane MT-MMPs are not merely redundant and specific functions 
have been described. The major example is MT1-MMP knockout mice that can not survive by the 
compensatory activity of other MT-MMPs (Holmbeck et al., 1999; Sakamoto and Seiki, 2009; 
Zhou et al., 2000). Moreover, Dr. Weiss´ laboratory has also shown specific roles of these 
proteinases. Although MT1-, MT2- and MT3-MMP can degrade collagen in vitro, it has been 
observed that MDCK cells overexpressing each of these metalloproteinases showed different 
invasion phenotypes in a three-dimensional collagen gel system. MDCK cells overexpressing 
MT1- or MT3-MMP presented an invasive response after SF/HGF stimulation in contrast to MT2-
MMP overexpressing cells that formed a disorganized multilayered structure atop the collagen 
matrix (Hotary et al., 2000).  
 
      Although MT-MMPs have overlapping functions and target common substrates, their 
differential expression within specific tissues may specify their functions. For example, during 
submandibular gland development expression of MT2-MMP is higher in the epithelium and MT1- 
and MT3-MMP are more abundant in the mesenchyme. Moreover, Rebustini and coll. showed 
that MT2-MMP-siRNA had the greatest effect on epithelial morphogenesis of the submandibular 
gland (number of end buds x duct length) compared with MT1- and MT3-MMP-siRNA. Similar 
results were obtained when epithelial proliferation was checked; MT2-MMP-siRNA significantly 
decreased epithelial cell proliferation whereas MT1- and MT3-MMP-siRNA had minimal effects on 
epithelial proliferation (Rebustini et al., 2009). 
 
      MT-MMP activity regulation by TIMPs can be another mechanism to explain different MT-
MMP functions. All transmembrane MT-MMPs can activate proMMP-2; however, their shedding 
mechanism is not the same. MT2-MMP, contrary to MT1-MMP, activates proMMP-2 in a pathway 
that is not dependent on the presence of TIMP-2, but rather on interaction with the hemopexin-like 
domain of MMP-2. Based on this different shedding mechanism, it can be speculated that MT2-
MMP may be the main metalloproteinase for proMMP-2 shedding in tissues or pathologies 
characterized by low TIMP-2 expression (Morrison et al., 2001; Morrison and Overall, 2006). 
Regarding regulation, it has been also observed that MT3-MMP is regulated by its internalization 
and that this internalization occurs together with MT1-MMP. Both proteins are transported to 
trans-Golgi by early endosomes and they are also again driven together to the cell surface (Wang 
et al., 2004b).  
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Figure 4: Human MT-MMP cytosolic tail comparison. A) Amino acid sequences of the 
cytoplasmic domain of the MT-MMPs. Negative residues are coloured in blue, positive 
residues in red, non polar residues in green and uncharged polar residues are in black. PDZ 
binding motif is underlined. B) Phylogram (ClustalW EBI) obtained by analyzing and comparing 
these cytosolic sequences. 
      MT5-MMP seems to have several differences compared with the rest of transmembrane MT-
MMPs. It is the only one that presents two dibasic domains that can be recognized by 
convertases leading to shedding of MT5-MMP from the cell surface as a soluble enzyme. 
Moreover, its function seems to be mainly restricted to nervous system where it is predominately 
expressed (Pei, 1999). In spite of this apparent specificity, it has been observed that MT3-MMP 
expression pattern is similar to MT5-MMP in mouse carcinoma P19 cells differentiated to neurons 
by retinoic acid treatment. On the contrary, expression of MT1- and MT2-MMP was not induced 
by this treatment (Hayashita-Kinoh et al., 2001). For MT5-MMP possible redundancy with other 
MT-MMPs can be speculated, as it has been described for the rest of transmembrane MT-MMPs. 
Nevertheless, no double knockout mice of MT5-MMP and another MT-MMP to study in vivo 
redundancy have been generated to date. 
 
2.5.2. Cytosolic tail comparison  
 
      MT-MMP cytosolic tails can be also involved in the redundancy and specificity of the 
transmembrane MT-MMPs. Studies about MT-MMP cytosolic tails have mainly been focused on 
MT1- and MT5-MMP. Because of this, very little about common or specific features of MT-MMP 
cytosolic tails can be concluded. However, indirect analysis to predict possible redundant or 
specific functions can help to clarify this issue. 
 
      Comparison of the cytosolic tail residues of the MT-MMPs can give us clues about the 
existence of common or different motifs than can affect MT-MMP regulation or function. 
Moreover, based on MT-MMP cytosolic binding motifs, interacting proteins can be predicted. As 
shown in Figure 4A, cytosolic domains of MT-MMPs share part of their sequence. The four of 
them have two or three polybasic regions, two hydrophobic regions and a PDZ binding sequence 
at their C-termini.  
      To analyze the relationship between the MT-MMP cytosolic tails we first compared their amino 
acidic sequence with a phylogram (Fig. 4B). By this analysis, it can be observed that MT1-MMP 
and MT2-MMP are closely related, MT2-MMP and MT3-MMP also share a high percentage of 
their sequence and MT5-MMP is the one that differs more from the rest. As mentioned, MT5-
Metalloproteinase Cytoplasmic domain 
         MT1-MMP             RRHGTPRRLLYCQRSLLDKV  
         MT2-MMP             QRKGAPRVLLYCKRSLQEWV 
         MT3-MMP             KRKGTPRHILYCKRSMQEWV 
         MT5-MMP             KNKTGPQPVTYYKRPVQEWV  
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MMP has been described to have other differences with the rest of the transmembrane proteins 
such a unique dibasic motif that can let MT5-MMP to behave as a soluble protein. This phylogram 
obtained by cytosolic tail comparison shows the same relations between the four proteins that 
when their catalytic sequence is compared (Nie and Pei, 2003). 
 
Moreover, as explained previously, MT1-MMP cytosolic tail has a role in MT1-MMP 
internalization. MT1-MMP LLY573 motif of the cytosolic tail acts as a binding site for AP-2 
complex that mediates incorporation of target proteins into clathrin-coated pits. This sequence 
motif is present in MT2- and MT3-MMP which are also effectively internalized from the cell 
surface, but is absent in MT5-MMP that is less efficiently internalized (Uekita et al., 2001). Based 
on this, binding of MT2- and MT3-MMP, but not MT5-MMP, to AP-2 can be suggested.  
 
In regard to MT-MMP recycling, similar functions of MT1- and MT3-MMP cytosolic tails have 
been observed.  Wang and coll. showed that the deletion of the three last residues of the cytosolic 
tail of MT1-MMP (DKV) or MT3-MMP (EWV) significantly impaired their recycling after an 
apparently normal internalization process (Wang et al., 2004b).  
 
The relevance of the amino acid sequence of the MT-MMP cytosolic tails can be indirect 
evaluated by their degree of conservation along evolution. For this purpose, we compared MT-
MMP cytosolic residues of the species whose DNA has been sequenced. As it can be seen in the 
Table 3, the MT-MMP cytosolic tails are highly conserved along evolution, being nearly identical 
in separated taxons. This can indicate a key role of these amino acids for the correct function of 
the metalloproteinases. Moreover, this analysis can also point to conserved interactions of the 
MT-MMPs with cytosolic partners along evolution. 
 
Table 3: Comparison of the amino acids of MT-MMPs cytosolic tails. Different amino acids to the human 
sequence are highlighted in red. Animals belonging to Class Mammalia are coloured in green. 
 
Sequence of the cytosolic tail amino acids 
Taxon Animal Scientific name MT1-MMP MT2-MMP MT3-MMP MT5-MMP 
Primates human Homo sapiens RRHGTPRRLLYCQRSLLDKV QRKGAPRVLLYCKRSLQEWV KRKGTPRHILYCKRSMQEWV KNKTGPQPVTYYKRPVQEWV 
mouse Mus musculus RRHGTPKRLLYCQRSLLDKV QRKGAPRMLLYCKRSLQEWV KRKGTPRHILYCKRSMQEWV KNKAGPQPVTYYKRPVQEWV 
Rodents 
rat Rattus norvegicus RRHGTPKRLLYCQRSLLDKV QRKGAPRMLLYCKRSLQEWV KRKGTPRHILYCKRSMQEWV KNKTGPQPVTYYKRPVQEWV 
Even-toed 
ungulates cow 
Bos Taurus 
 RRHGTPKRLLYCQRSLLDKV QRKGAPRMLLYCKRSLQEWV KRKGTPRHILYCKRSMQEWV KNKAGPQPVTYYKRPVQEWV 
Lagomorphs rabbit Oryctolagus cuniculus RRHGTPKRLLYCQRSLLDKV   KNKAGPQPVTYYKRPVQEWV 
Carnivores dog Canis familiaris RRHGTPKRLLYCQRSLLDKV  KRKGTPRHILYCKRSMQEWV  
Chiropterous bat Rhinolophus ferrumequinum    KNKAGPQPVTYYKRPVQEWV 
zebrafish Danio rerio   KRKDTQRHILYCKRSMQEWV KNKNVQQHVTYYKHPVQEWV 
Fish 
medaka Oryzias latipes  QSKGAPRLLVHCKRSLQDWV KKKGTPRHILYCKRSMQEWV  
Birds chicken Gallus gallus   KREGTPRHILYCKRSMQEWV KNKEVQQNVVYYKRPVQEWV 
Amphibians westem frog 
Xenopus 
tropicalis RQCGTPKRILYWQRSLLDKV HRKGPPKALRYCKRSLQEWV KRKGTPRHILYCKRSMQEWV  
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3. Linker proteins to actin machinery 
 
      One key mechanism for MT-MMP function and activity regulation is the control of their 
localization at specific cellular microdomains and dynamic shuttling between these distinct 
compartments. In this regard, MT-MMP-integrin crosstalk has been seen to play an important 
role. For example, MT1-MMP is detected together with integrin αvβ3 in caveolae at membrane 
protrusions (filopodia and lamellipodia) of migrating cells where MT1-MMP was found to be 
active. Moreover, the association of these proteins is involved in several events as for example 
tumor cell locomotion (reviewed in(Gonzalo et al., 2010b). Integrin receptors connect the 
extracellular matrix to the actin cytoskeleton. However, integrin binding to actin filaments is not 
direct but requires adaptor proteins that form, together with signaling proteins, macromolecular 
complexes. Then, they not only anchor the cell to the substratum but also can transmit signals in 
both directions. These complexes have been seen to be important for different cellular functions 
such as cell motility or polarization (Geiger et al., 2001). For example, in healing skin wounds 
integrin-mediated cues promote the reorganization of the cytoskeleton of keratinocytes at the 
wound edge resulting in directed migration and wound closure (Brakebusch and Fassler, 2003).      
As MT-MMPs have been seen to participate in integrin associated protein complexes, a role of 
membrane protein linkers to actin cytoskeleton could be suggested for MT-MMP regulation. In this 
section three of these linker proteins will be explained in detail. 
 
3.1. p130Cas  
 
MT1-MMP cytosolic tail was reported to bind to the focal adhesion protein p130 Crk-
associated substrate (p130Cas) at the leading edge of migrating endothelial cells and this 
association was induced by sphingosine-1-phosphate (S1P) (Gingras et al., 2008).  
 
p130Cas is localized at cellular sites of dynamic interaction between the actin cytoskeleton 
and the plasma membrane. In fibroblasts, tyrosine-phosphorylated p130Cas is prominently 
localized at mature focal adhesions, while the unphosphorylated protein appears to be largely 
cytoplasmic. In migrating cells, tyrosine-phosphorylated p130Cas is enriched at the cell periphery 
in nascent cell-matrix adhesion sites (focal complexes) and/or plasma membrane ruffles (Abassi 
et al., 2003). In the case of osteoclast-like cells, p130Cas is localized in the peripheral sealing 
zone (Lakkakorpi et al., 1999).  
 
     p130Cas is a non-enzymatic ‘docking protein’ consisting of multiple protein-protein interaction 
domains and serve as an important anchoring point for protein-protein interactions (Nojima et al., 
1996). It presents an N-terminal Src homology 3 (SH3) domain that binds FAK and Pyk2, an 
interior substrate domain (SD) characterized by 15 Tyr-X-X-Pro (YxxP) motifs, a C-terminal Src 
binding domain and a highly conserved C-terminal region that binds to the Nsp family of proteins 
(Nsp1, And-34, and Chat) (Fig. 5A) (Defilippi et al., 2006).  
 
      The 15 YxxP motifs of the substrate domain represent the major sites of p130Cas tyrosine 
phosphorylation. Tyrosine phosphorylation creates docking sites for recruitment of SH2-
containing signaling effectors. Notably, recruitment of Crk adaptor proteins to this domain sites 
has been strongly implicated in promoting Rac activation and cell motility (Fig. 5B) (Pratt et al., 
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2005). Moreover, repetitive YxxP motifs have been suggested to mainly function in signal 
amplification to maximize the Crk output pathways, but also to diversify signaling, as functional 
cooperation in the Crk assemblages would also increase the repertoire of output signals, for 
example during integrin-mediated spreading and migration on ECM molecules (Fig. 5C) (Cary et 
al., 1998). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Structural characteristics and interacting proteins of p130Cas. A) p130Cas is a nonezymatic 
scaffolding protein that contains, an N-terminal SH3 domain that binds FAK and Pyk2, 15 repeats of a YxxP 
motif, a serine-rich motif that binds Src kinases, and a conserved C-terminal region that binds members of 
the Chat family of proteins. B) Signal transduction by the p130Cas scaffold protein. The central substrate 
region of p130Cas (shown in panel B as a compressed configuration) is activated by mechanical force and 
‘extension’ of the central region. C) This would activate Src, induce tyrosine phosphorylation of the repetitive 
YxxP motifs, and recruit Crk through its SH2 domain. Further, by recruiting different proteins via the 
CrkSH3N, this signaling strategy would spatially integrate divergent signals, for example, after the 
recruitment of various GTPase pathways such as DOCK1, SOS, and C3G (Taken from(Birge et al., 2009). 
 
      Activity regulation of p130Cas occurs as a consequence of phosphorylation of multiple YxxP 
tyrosine residues in the SD. p130Cas SD tyrosine phosphorylation appears to be mediated 
primarily by Src-family kinases and occurs as a consequence of integrin-mediated cell adhesion. 
The SD is characterized by 15 YxxP motifs and the most N-terminal of these YxxP tyrosines, are 
subject to phosphorylation by Src. The 10 most C-terminal YxxP sites appear to be the most 
efficiently phosphorylated. Phosphospecific antibodies directed against SD YxxP 
phosphotyrosines indicate p130Cas is activated within focal adhesions and at the cell periphery of 
motile cells (Cabodi et al., 2010). 
 
      p130Cas is involved in different cellular functions. p130Cas-null cells show defects in stress 
fiber formation, cell spreading, impaired actin bundling and cell migration, which are restored by 
the addition of full-length p130Cas (Honda et al., 1998). By contrast, mutants with deletions of the 
YxxP motifs in the SD and of the C-terminal Src-binding domain can not recover the migratory 
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phenotype, probably because of their inability to bind Crk and to associate and regulate Src 
kinase (Huang et al., 2002). p130Cas presents also a role in cell survival and apoptosis. p130Cas 
is an important transducer of survival signals. Pro-survival signals emanating from the ECM, 
soluble growth factors and hormones proceed through their respective receptors, then through 
FAK and Src to p130Cas, activating the small GTPases Ras and Rac. Moreover, p130Cas is also 
required for integrin-dependent EGF-receptor activation, which in turn leads to cell survival (Moro 
et al., 2002). However, p130Cas has also a direct role in death signaling. Cell detachment triggers 
rapid dephosphorylation of p130Cas in anoikis-(apoptosis induced by cell detachment) sensitive 
normal epithelial but not in anoikis-resistant lung adenocarcinoma cells (Wei et al., 2002). Finally, 
p130Cas is involved in cell transformation, invasion and cancer. For example, p130Cas has been 
seen to be hyperphosphorylated in Src- and Crk-transformed cells (Reynolds et al., 1989). 
 
      p130Cas-deficient mouse embryos die in uterus and are phenotypically abnormal at 11.5-
12.5 days post coitum with systemic congestion, growth retardation and heart and blood vessel 
abnormalities (Honda et al., 1998). 
 
3.2. Moesin                        
 
As mentioned, radixin has been described to interact in vitro with the MT1-MMP cytosolic tail 
(Terawaki et al., 2008). Due to the known functions of ERM proteins and the established 
preferences in their binding features, it is probable that MT1-MMP could interact not only with 
radixin but also with other members of ERM family.  
 
      Moesin and the rest of ERM family members display the same structure (Fig. 6). They are 
formed of three domains; an N-terminal globular domain, also called FERM domain (Four-point 
one, Ezrin, Radixin, Moesin), which allows ERM proteins to interact with integral proteins of the 
plasma membrane or scaffolding proteins localized beneath the plasma membrane, an extended 
alpha-helical domain (coiled coil) and a C-terminal domain (ERM Actin and FERM-Binding 
Domain; A/FBD) which mediates the interaction with F-actin. 
 
ERM proteins are conformationally regulated; the full-length (FL) dormant molecule has 
masked activities that can be revealed by activation of the full-length protein or expression of 
separated fragments. For example, soluble full-length dormant ezrin does not bind F-actin or the 
ERM-binding phosphoprotein 50 (EBP50), whereas the N-terminal domain alone binds EBP50, 
and the C-terminal domain alone binds F-actin (Gary and Bretscher, 1995). The molecular basis 
for this phenomenon was uncovered by the finding that in dormant ezrin the N-terminal domain 
binds very tightly to its C-terminal domain and thereby masks the binding sites for EBP50 and F-
actin. Because these domains can mediate interactions of the different ERM members, they were 
given the functional names N- and C-ERMADs (N- and C-ERM-association-domains) (Gary and 
Bretscher, 1995). 
 
Activation of ERM proteins was predicted to require the separation of the N- and C-ERMADs, 
thereby exposing the C-terminal F-actin binding site and potential membrane association sites in 
the N-ERMAD (Berryman and Rood, 1995). In vitro activation of dormant moesin by protein kinase 
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C-θ (PKC-θ), phosphorylates a specific C-terminal threonine (Pietromonaco et al., 1998), which 
reduces the   N-/C-ERMAD interaction (Matsui et al., 1998) and simultaneously unmasks both the 
EBP50 and F-actin binding sites, validating the conformational activation model (Fig. 6) (Simons 
et al., 1998).  
 
ERM proteins have been shown to participate in two types of interactions with membrane 
proteins. Direct associations involve interactions with the cytoplasmic domains of adhesive type I 
membrane proteins, whereas indirect associations through the adaptor EBP50 involve the 
cytoplasmic domains of proteins that span the membrane many times (Fig. 6).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: A model of the activation and function of ERM proteins. (a) ERM proteins exist in a dormant, 
monomeric form in which the FERM/N-ERMAD domain is associated with the C-ERMAD. (b) Local 
production of phosphatidylinositol bisphosphate (PIP2) recruits ERM proteins to the plasma membrane, 
which places them in a location to be phosphorylated, and thereby activated, by Protein Kinase Cθ. 
Activated ERM proteins can then participate in microfilament-membrane linkage by direct association with 
transmembrane proteins, (c) or indirectly through scaffolding molecules such as EBP50. ICAM: intercellular 
adhesion molecule, NHE: sodium-hydrogen exchanger, NHE-RF: regulatory cofactor of NHE-3, PDGF-R: 
platelet-derived growth factor receptor (Adapted from(Bretscher et al., 2002).  
 
By mapping the regions of interaction of ERM proteins, it has been observed that positively 
charged regions adjacent to the membrane of type I proteins play an important role for their 
affinity for ERMs. A positively charged juxtamembrane cluster binding to ERM proteins was found 
in CD43, CD44 and ICAM-2 (Legg and Isacke, 1998; Yonemura et al., 1998). 
 
ERM proteins are widely distributed membrane-associated proteins that regulate the structure 
and function of specific domains of the cell cortex. As linkers of transmembrane proteins to actin 
cytoskeleton, ERMs have been involved in different cellular functions. ERMs are implicated not 
only in cell-shape determination but also in migration, membrane-protein localization, membrane 
transport and signal transduction (Bretscher et al., 2002). For example, ezrin interacts with the 
cytoplasmic tail of ICAM-2 (Fig. 6) and this has been shown of functional importance. Natural 
killer cells need to recruit ICAM-2 into a bud-like projection known as uropod before they can be 
activated by IL-2 binding. This recruitment of ICAM-2 is dependent on ezrin, as cells that lack 
ezrin have uniform ICAM-2 distribution (Helander et al., 1996). Another example of ERM function 
   Actin 
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is their participation in Rho and PKC signaling, ERM activation has a crucial role in the cellular 
cytoskeletal response to Rho-pathway activation (Mackay et al., 1997). Moreover, ezrin has been 
seen to participate in endocytic recycling system. In the acid-secreting parietal cells of the 
stomach the H+-ATPase is sequestered in vesicles in resting cells, and upon stimulation vesicles 
fuse with plasma membrane. Ezrin becomes phosphorylated during this process, and apical 
microvilli are greatly enlarged to accommodate the added membrane (Agnew et al., 1999; Hanzel 
et al., 1989). In addition, moesin has been shown to play a crucial role in the generation of a rigid 
and uniform cell cortex during mitosis (Carreno et al., 2008), in the establishment of embryo 
polarity (Jankovics et al., 2002) and in the maintenance of epithelial integrity (Speck et al., 2003). 
Finally, a role of ERM in pathology has also been found. Estecha and coll. work showed that 
moesin plays a role in cell tumor invasion (Estecha et al., 2009).  
 
      Regarding ERM-deficient mice, moesin-deficient mice are the only ones generated to date 
and no abnormalities were detected. Interestingly, no compensatory up-regulation of ezrin or 
radixin in these mice was seen (Doi et al., 1999). 
 
3.3. Zonula Occludens 1     
 
As explained before, MT-MMPs have in the C-terminus of their cytosolic tails a PDZ binding 
motif and therefore, proteins with PDZ domains are likely to interact with them. In fact, this kind of 
interactions have been already described in the case of MT5-MMP binding to Mint-3 (Wang et al., 
2004a), ABP or GRIP (Monea et al., 2006).   
 
PDZ domains are protein-protein recognition modules that play a central role in organizing 
multiprotein complexes that function in signaling, as well as in the establishment and maintenance 
of cell polarity (Harris et al., 2001). PDZ domains recognize specific C-terminal motifs, usually 
about five residues in length, of their partner proteins, most often in the cytoplasmic tails of 
transmembrane receptors  (Kornau et al., 1995).  
 
Among the different proteins that contain PDZ domains we will focus in this work on Zonula 
Occludens 1 (ZO-1). ZO-1 belongs to the membrane associated guanylate kinase family 
(MAGUK) and it has the following structure: three PDZ domains, a Src homology (SH3) domain, 
a guanylate kinase (GK) domain and a praline-rich region that binds to the actin cytoskeleton  
(Fig. 7) (Guillemot et al., 2004). 
 
 
 
 
 
 
 
Figure 7: Diagram of ZO-1 domains. From the N-terminus to the C-terminus ZO-1 contains a core of PDZ 
domains, a basic Maguk core of Src homology (SH3), an enzymatically inactive guanylate kinase (GK) 
domain and a proline-rich domain (P). The alternative splice of regions of ZO-1 are indicated by Greek 
characters. Nuclear localization signals, arrowheads, and some binding proteins are also indicated (Adapted 
from(Gonzalez-Mariscal et al., 2000). 
                 PDZ2                SH3                        α                                 P                  γ  β 
      PDZ1                   PDZ3           GK
ZO-1                    Occludin 
ZO-2                    α-catenin   Actin 
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ZO-1 is a tight junction (TJ)-associated protein, with a molecular weight between 210 and   
225 kD, which is located at the submembranous region of the junction where acts as a linker 
between the proteins that constitute the TJ strands and the actin-based cytoskeleton. It is 
specifically enriched at the TJ of epithelial and endothelial cells. The most characterized function 
of ZO-1 is its role in TJ conformation (Fig. 29 of the discussion). ZO-1 has been shown to be 
indispensable for TJ formation in epithelial cells; targeted disruption of the ZO-1 gene results in 
deficient TJ formation (Umeda et al. 2006).  
 
ZO-1 can be also localized in the membrane of subconfluent epithelial cells or at the edge of 
wounded monolayers (Gottardi et al., 1996). Tuomi and coll. showed that ZO-1 preferentially 
interacts with α5β1 integrin at the lamella of migrating cells. Moreover, disruption of ZO-1 binding 
to α5 cytoplasmic tail prevented the localization of ZO-1 at the leading edge. Furthermore, 
silencing of ZO-1 resulted in reduced directional cell motility (Tuomi et al., 2009).  
 
Moreover, ZO-1 has also been detected at the nucleus and nuclear localization and exporting 
signals have been identified in its sequence (Fig. 7). ZO-1 has been seen to associate to different 
proteins and participate in the control of gene expression. ZO-1 can bind the transcription factor 
ZONAB and regulate ErbB-2 promoter in a cell density-dependent manner (Balda and Matter, 
2000). 
 
      ZO-1-deficient mice are embryonic lethal. Embryos exhibit massive apoptosis in the 
notochord, neural tube area and allantois at E9.5. In the yolk sac, the ZO-1-deficiency induces 
defects in vascular development with impaired formation of vascular trees. In E8.5 WT mice 
embryos ZO-1 is expressed in almost all embryonic cells, presenting tight junction-localizing 
patterns. ZO-1 may affect cell remodelling and participate in tissue organization in both embryonic 
and extraembryonic regions, playing an essential role for embryonic development (Katsuno et al., 
2008).  
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General objective: 
 
To get further insights into the specific functions of MT1-MMP versus other MT-MMP 
subfamily members by the analysis of their cytosolic tail interactions. 
 
Specific objectives: 
 
1. Characterization of MT1-MMP cytosolic tail association with the adaptor protein p130Cas 
in myeloid progenitors. 
 
2. Characterization of MT1-MMP, MT2-MMP and MT3-MMP cytosolic tail binding to ERM 
proteins. 
 
3. Search of new molecular associations of MT-MMP cytosolic tails and analysis of their 
possible cellular function. 
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1. Antibodies                        
 
Primary and secondary antibodies used in this work are summarized in the following tables:  
 
Primary antibody Origin Company 
Annexin I mouse Iowa Gift from Mª Antonia Lizarbe (UCM) 
Annexin II mouse BD Transduction Laboratories Gift from Mª Antonia Lizarbe (UCM) 
β-Actin mouse Sigma-Aldrich 
Caveolin-1 mouse BD Transduction Laboratories 
Ezrin rabbit Upstate 
GST rabbit Molecular Probes 
HA mouse Covance 
Integrin β1 rabbit Abcam 
Moesin rabbit Upstate 
MT1-MMP mouse LEM 2/63. Generated in our group (Galvez et al., 2001) 
MT2-MMP mouse R&D Systems 
MT2-MMPcyt rabbit Gift from Kaisa Lehti (University of Helsinki) 
p130CAS rat Pharmingen 
Rho-GDI rabbit Santa Cruz Biotechnology 
Tubulin mouse Abcam 
ZO-1 rabbit Zymed 
 
Secondary antibody Origin Company 
Anti mouse/rabbit/rat  
peroxidase conjugated goat Jackson Immuno-Research Laboratories 
Anti mouse/rabbit/rat 
conjugated with  
Alexa 488 or 647  
goat Jackson Immuno-Research Laboratories 
 
 
2. Cell cultures  
 
MT1-MMP bone marrow progenitors (BM) were obtained from MT1-MMP-deficient mice 
(MT1-MMP-/-). MT1-MMP-/- mice in the C57BL/6 background were generated as described (Zhou 
et al., 2000). BM cells were cultured in α-MEM (Lonza) supplemented with 10% FBS, 50 IU/ml 
penicillin, 50 µg/ml streptomycin. During 3 days cells were exposed to 50 ng/ml nuclear factor-kB 
ligand (RANKL) (PreproTech) and 50 ng/ml macrophage colony-stimulating factor (M-CSF) 
(PreproTech). After, for 9 days more cells were exposed to 50 ng/ml RANKL and 25ng/ml of M-
CSF. These conditions differentiate progenitors toward osteoclast (OC), giving rise to typical 
multinucleated cells expressing characteristic phenotypic markers, including tartrate-resistant acid 
phosphatase (TRAP) (Sigma) (Yagi et al., 2005). 
 
Human umbilical vein endothelial cells (HUVECs) were obtained and cultured as described 
previously (Galvez et al., 2001). Cells were grown in plates covered with 0.5% or 1% gelatin 
(Sigma-Aldrich) in 199 Bio Whittaker Medium (Walkersville, MD) supplemented with 10% fetal 
bovine serum (FBS), 2 mM L-glutamine, 50 IU/ml penicillin, 50 µg/ml streptomycin and 2.5 µg/ml 
of fungizone. After the first passage, 50 µg/ml of growth factor extracted from bovine cerebrum 
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and 10 UI/ml of heparin was also added to the medium. Cells at passage 3 or below were used in 
all assays.  
 
Bovine aortic endothelial cells (BAEC) were obtained with the following protocol. Briefly, aortic 
adventicia layers were removed and small vessels arising from the aorta were closed with a 
string. After washing with PBS, 0.1% collagenase was added into the aorta cavity. After              
10 minutes of incubation at RT detached cells were collected. BAEC were cultured in RPMI 1640 
medium supplemented with 10% FBS, 2 mM L-glutamine, 50 IU/ml penicillin, 50 µg/ml 
streptomycin over 0.1% gelatin coated plates. Cells at passage 5 or below were used in all 
assays. 
 
Human microvascular endothelial cells (HMECs) were cultured in MCDB131 medium (Gibco, 
Invitrogen Corporation) supplemented with 10% FBS, 2 mM L-glutamine, 50 IU/ml penicillin,      
50 µg/ml streptomycin, 10 ng/ml EGF (Promega) and 100 nM hydrocortisone (Sigma).  
 
HeLa and MDA-MB-231 cells were cultured in DMEM (Gibco, Invitrogen Corporation) 10% 
FBS, 2 mM L-glutamine, 50 IU/ml penicillin and 50 µg/ml streptomycin. 
 
NCI-H441 and NCI-H441 were cultured in RPMI 1640 medium supplemented with 10% FBS,   
2 mM L-glutamine, 50 IU/ml penicillin, 50 µg/ml streptomycin. 
 
MDCK type II were cultured in MEM (Gibco, Invitrogen Corporation) supplemented with       
5% FBS, 2 mM L-glutamine, 50 IU/ml penicillin, 50 µg/ml streptomycin.  In the case of the stable 
transfected MDCK 400 µg/ml neomycin (G418) (Sigma-Aldrich) was also added to the culture 
medium.  
 
3. Cell interference 
 
      One day after seeding, cells were transfected with 100nM or 200nM moesin/control 
interference RNA (Ambion) using Oligofectamine reagent (Invitrogen). After 48, 72 or 96 h cells 
were lysed (lysis buffer: 10 mM Tris-HCL, 1% Triton X-100, 0.5% sodium deoxycolate, 0.1% SDS, 
150 mM NaCl, 5 mM EDTA, 10 mM MgCl2, proteinase inhibitor cocktail (Roche), 0.2 mg/ml 
PMSF, 25 mM NaF and 1 mM Na3VO4) and membrane fractionation or western blot was 
performed. 
 
4. MDCK stable transfection and clone selection   
 
MDCK were transfected with pCR3.1 empty vector (mock) or pCR3.1 containing the cDNA 
fragments: MT1-MMP-HA, MT1-MMP-K581W-HA, MT2-MMP-HAFlag or MT2-MMP-W668K-
HAFlag. For transfection FuGENE 6 (Roche) was used. Transfected MDCK cells were cultured in 
the presence of 400 µg/ml of G418 and single cell colony selection was performed by limited cell 
dilution in 96-well plates. Each cell clone was tested for the corresponding MT-MMP expression 
by immunoflourescence and western blot.    
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5. Cell infection 
 
Retroviral particles were collected from conditioned medium after transfection of plasmids into 
the proper packaging cell lines (Viral Vector Unit, CNIC). As a control, BM cells were infected with 
retroviral particles obtained with the empty plasmids (pMSCV/pRETRO). BM cells were infected 
on day 0 and washed 48 h after infection. 
 
6. Expression vectors and plasmid construction  
 
The MT1-MMP retroviral construct has been previously described (Bartolome et al., 2009). 
The pR-MT1-MMP-Y573F mutant was generated from the pRETRO-MT1-MMP plasmid with the 
Quick Change site-directed Mutagenesis kit (Stratagene) according to the manufacturer’s 
instructions. The primers used for this mutation were: fw: GACTGCTCTTCTGCCAGCG and rv: 
CGCTGGCAGAAGAGCAGTC. 
 
GST and MT1-, MT2-, MT3- and MT5-MMP cytosolic tail GST fusion proteins were obtained 
by direct cloning (Fig. 8). PGEX-4T2 vector was digested with BamH I and Xho I and the DNA 
sequences corresponding to the cytosolic tails flanked with BamH I and Xho I sites were ordered 
(Fig. 8B and C). The oligonucleotides were heated for 5 min at 94ºC and cooled slowly for 
hybridization. Hybridized oligonucleotides were added to digested pGEX-4T2 and ligation was 
performed by T4 ligase.  
 
 
 
 
 
 
 
 
 
 
 
 
 
The cytosolic tail mutants of MT1- and MT2-MMP, K581W and W668K respectively, were 
performed with Quick Change site-directed Mutagenesis kit (Stratagene). The primers used for 
Construct Oligonucleotides 
MT1-MMPcyt Fw: GATCCAGACGCCATGGGACCCCCAGGCGACTGCTCTACTGCCAGCGTTCCCTGCTGGACAAGGTCTGAC Rv: TCGAGTCAGACCTTGTCCAGCAGGGAACGCTGGCAGTAGAGCAGTCGCCTGGGGGTCCCATGGCGTCTG 
MT2-MMPcyt Fw: GATCCCAGCGCAAGGGTGCGCCACGTGTCCTGCTTTACTGCAAGCGCTCGCTGCAGGAGTGGGTCTGA Rv: TCGATCAGACCCACTCCTGCAGCGAGCGCTTGCAGTAAAGCAGGACACGTGGCGCACCCTTGCGCTGG 
MT3-MMPcyt Fw: GATCCAAGAGGAAAGGAACACCCCGCCACATACTGTACTGTAAACGCTCTATGCAAGAGTGGGTGTGA Rv: TCGATCACACCCACTCTTGCATAGAGCGTTTACAGTACAGTATGTGGCGGGGTGTTCCTTTCCTCTTG 
MT5-MMPcyt Fw: GATCCAAGAACAAGACAGGCCCTCAGCCTGTCACCTACTATAAGCGGCCAGTCCAGGAATGGGTGTGA Rv: TCGATCACACCCATTCCTGGACTGGCCGCTTATAGTAGGTGACAGGCTGAGGGCCTGTCTTGTTCTTG 
BA 
C 
Figure 8: Cloning of the MT-MMP cytosolic tails in pGEX-4T2 vector. A) Diagram of pGEX-4T2 vector. B) 
Cloning strategy. C) Oligonucleotides used for the cloning of MT-MMP cytosolic tail cDNA sequences in 
pGEX-4T2 vector.  
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these mutations were; fw: CAGCGTTCCCTGCTGGACTGGGTCTGATAGAAGCCG and rv: 
CGGCTTCTATCAGACCCAGTCCAGCAGGGAACGCTG for MT2-MMP-K581W and fw: GCGC 
TCGCTGCAGGAGAAGGTCTGAAATTCTGCAG and rv: CTGCAGAATTTCAGACCTTCTCCTG 
CAGCGAGCGC for MT2-MMP-W668K. All constructs were finally sequenced at the Genomic 
Service of the Spanish National Cancer Research Centre (CNIO). 
 
      To construct a putative catalytically inactive MT2-MMP, the putative amino acid of its active 
site E267 was changed for an alanine. This mutation was performed with Quick Change site-
directed Mutagenesis kit (Stratagene). The primers used for this mutation were; fw: CTGGTGGC 
AGTGCATGCGCTGGGCCACGCGCTG and rv: CAGCGCGTGGCCCAGCGCATGCACTGCCA 
CCAG. 
 
7. Glutathione Sepharose-Transferase (GST) fusion protein production 
 
pGEX-4T2 constructs were used to transform Escherichia coli BL21 cells. For protein 
production, cells induced for 3 h with 500 mM isopropyl β-D-thiogalactoside were lysed using Cell 
Lytic Express (Sigma-Aldrich) supplemented with a proteinase inhibitor cocktail (Roche) and      
0.2 mg/ml PMSF. Fusion proteins were recovered by glutathione-sepharose 4B beads (GE 
Healthcare). The amount of fusion proteins was estimated by Coomassie Blue staining. Bands 
were quantified using Image J software. 
 
8. Pulldown assays 
 
8.1. Pulldown with GST fusion proteins  
 
Cells were lysed (lysis buffer: 50 mM Tris pH7.5, 1% Triton X-100, 0.1% SDS, 0.5% sodium 
deoxyicholate, 500 mM NaCl, 10 mM MgCl2, proteinase inhibitor cocktail (Roche), 0.2 mg/ml 
PMSF, 25 mM NaF and 1 mM Na3VO4) and the obtained lysates were precipitated with GST 
fusion proteins or GST alone. After washing (10-50 mM Tris ClH pH7.5, 0.5% Triton X-100,       
150 mM NaCl and 1 mM DTT), bound proteins were eluted by boiling in Laemmli buffer. Samples 
were run in SDS-PAGE and western blot or protein identification by mass spectrometry (MS) was 
performed. 
 
8.2. Pulldown with biotinylated peptides  
  
Cells were lysed with 1% NP40-TBS (with proteinase inhibitor cocktail (Roche), 0.2 mg/ml 
PMSF, 25 mM NaF and 1 mM Na3VO4) and N-terminal biotinylated peptides corresponding to the 
cytosolic tails of the different WT or MT-MMP mutants coupled with neutravidin beads were 
added. After overnight incubation, the precipitated was washed 6 times with 0.1% NP40-TBS and 
resuspended in Laemmli buffer for SDS-PAGE and western blot analysis.  
 
9. Coimmunoprecipitation  
 
For coimmunoprecipitation assays HeLa cells were transfected with FuGENE 6 (Roche) with 
MT1-MMP-HA, MT1-MMP-K581W-HA, MT2-MMP-HAFlag and MT2-MMP-W668K-HAFlag 
sequences all of them in PCR3.1. After 24 h, cells were lysed in 1% NP40-TBS with proteinase 
inhibitor cocktail (Roche), 0.2 mg/ml PMSF, 25 mM NaF and 1 mM Na3VO4. Lysates were 
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incubated for 1 h at 4ºC with 5 µg of anti-HA antibody. Immunoprecipitates were washed 6 times 
with 0.1% NP40-TBS and separated by 10% SDS-PAGE under reducing conditions. After 
transferring to nitrocellulose membrane (Bio-Rad) western blot was performed. 
 
10. Western blot 
 
For western blot, membranes were blocked with 5% BSA-PBS. Next, primary antibodies,   
diluted in 2% BSA-PBS, were incubated for 1h at RT. After, membranes were washed with 0.2% 
Tween 20-PBS and then they were incubated for 1 h at RT with a horseradish peroxidase-
conjugated antibody. Finally, membranes were again washed and protein bands were visualized 
by enhanced chemiluminescence (ECL; Amersham Pharmacia Biotech, Buckinghamshire, United 
Kingdom). Densitometric analysis of band intensity was done using Image J software. 
 
11. Mass Spectrometry 
 
Pulldown SDS-PAGE was stained with Coomasie Blue and the proteins corresponding to the 
observed bands, and the equivalent regions or the other lanes, were identified by Liquid 
Chromatography/Mass Spectrometry (LC-MS) in the CNIC Proteomic Unit (Fig. 9). For protein 
identification fragmentation spectra were searched against MSDB database using the 
MASCOTTM program. All identifications were performed by Data Analysis software (Bruker). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Example of a pulldown experiment. GST fusion proteins and control ones (only GST) were added 
to HMEC lysates. In the left the resulting pulldown resolved in a SDS-PAGE and stained with Coomasie 
Blue is depicted. In the right a diagram of the specific bands excised for LC-MS is shown. Equivalent 
regions of the observed bands in the other lines were also sequenced.  
 
12. Subcellular fractionation 
 
      For subcellular fractionation two methods were used. In p130Cas experiments, particulate and 
soluble fractions were obtained from cultured OC progenitors as previously explained (Del Pozo 
et al., 2002). Following this protocol two cell fractions corresponding to the plasma membrane 
proteins and the cytosolic ones were obtained. Briefly, cells were lysed with ice-cold hypotonic 
lysis buffer (10 mM Tris-HCl pH 7.4, 1.5 mM MgCl2, 5 mM KCl, 1 mM DTT, 1 mM Na3VO4,        
0.2 mg/ml PMSF, 1 μg/ml aprotinin and 1 μg/ml leupeptin) for 5 min. Homogenates were 
centrifuged at 1700 rpm for 3 min and the supernatants were then spun at 14000 rpm for 30 min 
at 4°C. Sediment (particulate fraction) and supernatant (cytosolic fraction) were collected. Equal 
protein amounts were analyzed by western blot and densitometry analysis was performed with 
           GST   GST-               GST         GST- 
                    MT1cyt                           MT1cyt 
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Quantity One or ImageJ software. The amount of p130Cas in the particulate fraction (normalized 
to β1 integrin levels) was calculated.  
 
      For MT1-MMP analysis in moesin interfered cells subcellular fractionation using Triton X-114 
was performed. With this method two cell fractions are obtained; one is formed of caveolae 
enriched membrane compartment and the other is formed of cytosolic proteins. Briefly, cells were 
lysed in 1.5% Triton X-114-TBS with proteinase inhibitor cocktail (Roche), 0.2 mg/ml PMSF,        
25 mM NaF and 1 mM Na3VO4. After centrifugation at 14000 rpm for 15 min at 4ºC, supernatants 
were incubated at 37ºC for 2 min. Afterwards, samples were spun at 10000 rpm for 5 min at RT. 
The two phases formed, corresponding to the aqueous and the hydrophobic phase, were 
separated and analyzed by western blot. Densitometry analysis was performed with Quantity One 
or ImageJ software.   
 
13. Immunofluorescence microscopy 
 
Cells were fixed with 4% paraformaldehyde in PBS for 10 min at RT, permeabilized for 15 min 
with 0.1% Triton-X-100 in blocking buffer (2% BSA, 10% FBS, 1 mM MgCl2 and 1 mM EDTA  in 
PBS) at 4ºC and then blocked for 1 h in the same buffer. Primary antibodies and Alexa-
conjugated secondary antibodies were incubated for 1 h at RT. For nuclear staining Hoescht 
33342 (Sigma) was used. Coverslips were mounted with Prolong mounting medium (Invitrogen). 
Samples were analyzed in a SPE Leica photomicroscopy and images were obtained with Leica 
LAS AF Software.  
 
14. ELISA  
 
Streptavidin binding plates (96 wells, Pierce) were incubated at 4ºC for 3 h in 0.1 M Na2CO3 
buffer (pH 9.6) containing 40 µM of biotinylated peptides (GenScript) corresponding to the MT-
MMP cytosolic tails: MT1-MMPcyt (563RRHGTPRRLLYCQRSLLD KV582), MT1-MMPcyt-
K581W, MT1-MMPcyt-RRH563AAA, MT1-MMPcyt-RR569AA, MT1-MMPcyt-R576A, MT1-
MMPcyt-S577A, MT2-MMPcyt (650QRKGAPRVLLYCKRSLQEWV669), MT2-MMPcyt-E667A, 
MT2-MMPcyt-W668K, MT2-MMPcyt-669∆V or MT3-MMPcyt (588KNKTGPQPVTYYKRPVQEW 
V607). To avoid non-specific binding to biotinylated peptides samples were blocked with           
2% BSA/TBS-Tween containing 10% FBS overnight at 4ºC. GST-tagged recombinant ZO-1PDZ1-
3, ZO-1PDZ1, ZO-1PDZ2, ZO-1PDZ3, moesin, N-moesin, C-moesin or GST alone was added to 
the wells in equal concentrations and incubated at RT for 1 h. After extensive washing, GST 
protein binding to the cytosolic tail sequences was detected using anti-GST Ab and HRP-based 
detection (Fig. 10). For the analysis of the results optical density of an empty well was subtracted 
from all the absorbance data obtained.   
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15. Surface plasmon resonance  
 
N-terminal biotinylated synthetic peptides corresponding to the cytoplasmic domain of MT1-, 
MT2-, MT3-MMP or MT2 mutant MT2-MMPcyt-669∆V were immobilized on a streptavidin sensor 
chip. GST-ZO1-PDZ2 in running buffer (10 mM Hepes pH 7.4, 100 mM NaCl, 0.005% NP40) was 
perfused (30 μl/min) over these analytes. Binding was monitored with a BIAcore 2000 instrument 
(BIAcore AB. Uppsala, Sweden) and MT2-MMPcyt-669∆V binding was subtracted from each 
curve. After 4 min of association, the sample solution was replaced by running buffer, allowing the 
complex to dissociate. The surface was regenerated through 1 min pulses of 1 M NaCl, 0.05 M 
NaOH (Fig. 11). The dissociation rate constants were analyzed using BIAevaluation 3.1 software 
from BIAcore AB (Uppsala, Sweden). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      MT-MMP cytosolic tail 
ZO-1PDZ2 
Figure 11: Surface plasmon resonance methodology (SPR). A) Fundamentals of how the interaction 
between two molecules is detected by SPR. As molecules are immobilized on a sensor surface, the 
refractive index at the interface between the surface and the solution flowing over the surface changes, 
altering the angle at which reduced-intensity polarized light is reflected from the supporting glass plane. The 
change in angle caused by association or dissociation of molecules from the sensor surface is proportional 
to the mass of bound material and is recorded in a sensorgram. B) Sensorgram. It provides real-time 
information about an interaction, with binding responses measured in response units (RU). C) 
Representation of MT-MMP cytosolic tail and ZO-1PDZ2 interaction in the SPR assays. 
C 
   Sensor surface 
      Glass slide 
Polarize light Prism 
A B 
Figure 10: Diagram of ELISA components 
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16. RT-PCR 
 
      Total RNA was extracted with Trizol (Invitrogen) and cDNA was prepared with Omniscript 
reagent (Qiagen). RT-PCR was conducted with primers for mouse MT1-MMP and GADPH, and 
human MT2-MMP and actin (Hikita et al., 2006; Jung et al., 2003). Products of PCR reactions 
were separated on 2% agarose gels.  
 
17. Cellular functional models 
 
17.1. MDCK cyst formation 
 
MDCK cysts were grown in 3D Matrigel cultures (BD, San Jose, CA). Cells were trypsinized to 
a single cell suspension at 1.5 × 104 cells/ml in complete medium containing 2% Matrigel. 
Suspensions were plated into 8-well coverglass chambers (Nunc, Rochester, NY) pre-coated with 
5 μl of 100% Matrigel. Cells were grown for 4 days before fixation with 4% PFA.  
 
17.2. MDCK polarization  
 
      For MDCK cell polarization cells were cultured on transwell filters (Costar) for 3-5 days (Oztan 
et al., 2008).  
 
 
18. F-actin quantification  
 
      Polarized MDCK cells were fixed with 4% PFA and stained for F-actin (Phalloidin-Texas Red). 
Pictures for Z axis were taken and apical and basal actin was measured with Metamorph 
software.  
 
19. Statistical analysis 
 
      Test and control samples were compared for statistical significance by using the Student´s t 
test. Differences were considered statistically significant at p<0.05.  
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1. Characterization of MT1-MMP cytosolic tail binding to p130Cas in myeloid 
progenitors 
 
1.1. The mutation of the unique tyrosine of MT1-MMP cytosolic tail decreases its binding to 
p130Cas 
 
MT1-MMP/p130Cas binding has been reported in endothelial cells (Gingras et al., 2008). 
Pulldown assays in myeloid progenitors confirmed that p130Cas could bind to the cytoplasmic 
domain of MT1-MMP (Fig. 12). It had been shown that S1P induced phosphorylation of MT1-
MMP on its unique cytoplasmic tyrosine residue (Nyalendo et al., 2007). Moreover, Gingras and 
coll. saw that p130Cas/MT1-MMP complex contained pMT1-MMP, indicating a possible 
interaction of the tyrosine phosphorylated form of MT1-MMP with p130Cas (Gingras et al., 2008). 
To test this hypothesis we generated a fusion protein in which the unique tyrosine of the MT1-
MMP cytosolic tail was mutated to a phenylalanine, which is unable to be phosphorylated. 
Pulldown assays were performed with this mutated fusion protein (GST-MT1-MMPcyt-Y573F) and 
WT one (GST-MT1-MMPcyt). As shown in Figure 12, this MT1-MMP mutant bound p130Cas less 
efficiently, showing that MT1-MMP Tyr 573 participates in MT1-MMP association with p130Cas.  
 
 
 
 
 
 
 
 
 
 
 
Figure 12: The mutation of MT1-MMP cytosolic tail tyrosine decreases its binding to p130Cas. GST fusion 
proteins of the MT1-MMP cytosolic tail (GST-MT1cyt) and a mutated version in which Y573 is replaced by F 
(GST-MT1cyt-Y573F) were used in pulldown assays; lysates from BM cells treated for 4 days with RANKL 
and M-CSF were used in these assays. A representative blot of p130Cas is shown. The histogram shows 
arithmetic means ± SE of densitometric quantification of the p130Cas/GST ratio normalized to GST-MT1cyt 
values (n = 3). 
 
 
1.2. p130Cas binding to MT1-MMP is required for proper p130Cas localization at the cell 
membrane 
 
We analyzed the possible contribution of MT1-MMP to p130Cas subcellular localization. For 
this purpose p130Cas localization in WT and MT1-MMP null myeloid progenitors was determined 
by cell fractionation and immunofluorescence assays. As it is depicted in Figure 13A, the amount 
of p130Cas in the plasma membrane was significantly decreased in MT1-MMP null progenitors.  
 
To check that this decrease was directly due to the absence of MT1-MMP, retroviral 
reexpression of MT1-MMP was performed. After infection, human MT1-MMP expression was 
detected by RT-PCR and western blot (Fig. 13B). Significant increase in the amount of p130Cas 
in the membrane fraction of null myeloid progenitors was obtained when MT1-MMP was re-
expressed (Fig. 13C). These data indicate that MT1-MMP is required for proper p130Cas 
localization at the cell membrane of these cells. 
    GST                    GST-                   GST-              
                             MT1cyt          MT1cyt-Y573F   
p130Cas 130 
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1.3. MT1-MMP cytosolic tyrosine is important for myeloid progenitor fusion 
 
To test the relevance of the MT1-MMP cytosolic tyrosine Y573, involved in p130Cas 
assembling, in MT1-MMP function in myeloid cell fusion, rescue experiments with MT1-MMP or 
MT1-MMP tyrosine mutant were performed. Retroviral expression of MT1-MMP was able to 
rescue the OC fusion phenotype of MT1-MMP null cells. However, MT1-MMP-Y573F could not 
rescue this phenotype. Since we have shown that MT1-MMP cytosolic tail tyrosine is important for 
MT1-MMP interaction with p130Cas, this result indicates that MT1-MMP Y573 might be required 
for myeloid progenitor fusion by its binding to p130Cas (Fig. 14). 
 
In conclusion, we have identified a novel signaling pathway for MT1-MMP regulation of 
myeloid progenitor fusion. This pathway involves the association of the MT1-MMP cytosolic tail 
with p130Cas. Our data not only confirm MT1-MMP-p130Cas interaction previously shown in 
endothelial cells (Gingras et al., 2008), also shows that the phosphorylation of MT1-MMP Tyr573, 
in the cytosolic tail, plays a role in its association with p130Cas. Moreover, MT1-MMP participates 
in the recruitment of p130Cas to myeloid progenitor cell membrane, as it is shown by the 
decrease in p130Cas membrane targeting in MT1-MMP null progenitors and the rescue of this 
targeting by reexpression of MT1-MMP in null cells. The importance of the interaction of Tyr573 
Figure 13: MT1-MMP is required for proper p130Cas localization at the cell membrane. A) p130Cas 
localization in WT and MT1-MMP null myeloid progenitors was analyzed by cell fractionation. Cells were 
fractionated and particulate/membranous (P) and soluble/cytosolic (S) fractions were analyzed by western 
blot; a representative blot is shown. The histogram shows arithmetic means ± SE of densitometric 
quantification of the p130Cas/β1 integrin ratio in the particulate fraction (n = 4 experiments from 20 mice). 
Images of cells stained for p130Cas (green) are shown. The scale bar indicates 20 μm. B) BM progenitors 
from WT or MT1-MMP null mice were infected with retrovirus encoding human MT1-MMP (pR-MT1-MMP) 
and cultured with M-CSF and RANKL for 4 days. Human MT1-MMP expression was detected by RT-PCR 
(upper panel) and western blot (botton panel). Mock, infection with the empty virus. C) Infected cells were 
fractionated, and particulate (P) and soluble (S) fractions were analyzed by western blot for p130Cas; a 
representative blot is shown. The histogram shows arithmetic means ± SE of densitometric quantification of 
the p130Cas/β1 integrin ratio in the particulate fraction (n = 5 independent experiments from 15 mice). 
A 
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with p130Cas for myeloid cell fusion is demonstrated by the inability of the MT1-MMP Y573F 
mutant to rescue the multinucleated phenotype. 
 
2. Characterization of MT1-, MT2- and MT3-MMP binding to ERM proteins 
 
2.1. MT1-, MT2- and MT3-MMP cytosolic tails bind to N-moesin in vitro 
 
Transmembrane MT-MMPs have two or three positive clusters in their cytosolic tails (Fig. 
15A) that make them good candidates for interacting with ERM proteins (Legg and Isacke, 1998). 
Moreover, crystal structure of MT1-MMP/radixin complex has been reported (Terawaki et al., 
2008). To investigate possible MT-MMP/ERM interactions ELISA assays were first performed 
(Fig. 10 of Materials and Methods). As depicted in Figure 15B, MT1-, MT2- and MT3-MMPs 
cytosolic tails can directly bind to moesin. To further characterize these interactions, we analyzed 
which domain of moesin was involved in the binding to MT1-, MT2- and MT3-MMP cytosolic tails. 
As expected, the cytosolic tails of these metalloproteinases bound to N-terminal moesin and no 
binding to C-terminal moesin was detected. Moreover, the cytosolic tails had much more affinity 
for N-terminal moesin that for FL-moesin (Fig. 15B). This increased affinity fits with the ERM 
activation model previously explained (Fig. 6 of the Introduction) (Tsukita et al., 1994). According 
with this model, in inactive FL-ERM their N-terminal domain is bounded tightly to its C-terminal 
domain masking their binding sites to other proteins (Gary and Bretscher, 1995). Because of this, 
when C-terminal moesin was removed, interaction of N-terminal moesin with MT-MMPs was 
increased.  
 
2.2. Characterization of MT1-MMP residues involved in moesin interaction 
 
We focused on MT1-MMP for detailed analysis of MT-MMMP/moesin interaction. To analyze 
which residues of the MT1-MMP cytosolic tail were involved in its interaction with moesin, ELISA 
assays with MT1-MMP mutants were performed. As ERM proteins bind preferably to polybasic 
clusters of transmembrane type 1 cytosolic tails (Legg and Isacke, 1998; Yonemura et al., 1998), 
we generated MT1-MMP mutants in which each of the polybasic and single positive residues 
were mutated to alanines (Fig. 15C).  As it is can be seen in Figure 15C, the juxtamembrane 
polybasic region of MT1-MMP (RRH563) is essential for its binding to N-moesin. In the case of 
the absence of the middle polybasic region of MT1-MMP cytosolic tail (RR569), significantly 
Figure 14: MT1-MMP cytosolic tyrosine is important for myeloid progenitor fusion. MT1-MMP null BM 
progenitors were infected with empty retrovirus (Mock) or retrovirus encoding non-mutated or Y573F 
mutated human MT1-MMP (pR-MT1-MMP or pR-MT1-MMP-Y573F) and cultured under osteoclastogenic 
conditions for 12 days. Images of TRAP+ cells are shown. The scale bars indicate 100 μm. The histogram 
shows arithmetic means ± SE of the number of TRAP+ cells containing ≥ 3 nuclei (n = 10). 
                                   Mock                             pRMT1-MMP                  pRMT1-MMP-Y573F 
                               MT1-MMP-/-                            MT1-MMP-/-                                       MT1-MMP-/- 
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reduced binding was also obtained. Finally, when distal MT1-MMP arginine 576 was mutated, no 
differences in moesin binding were detected.  
 
In addition to polybasic regions, serine residues have been also described to play a role in the 
binding of transmembrane type 1 proteins to ERMs (Serrador et al., 2002a). To test the relevance 
of MT1-MMP cytosolic tail unique serine, a mutant in which this serine was substituted for an 
alanine was used. As it is depicted in Figure 15C, no changes in moesin affinity for this mutant 
compared with the WT sequence were observed.  
 
Finally, when MT1-MMP or MT2-MMP mutants of the PDZ binding motif (Fig. 19D) were 
studied no differences in binding of these proteins to moesin were obtained (data not shown); 
similar results were obtained with a mutant in which MT1-MMP last positive residue (K581) was 
mutated. Thus, it can be concluded that this MT1-MMP last positive residue does not affect 
moesin binding. 
Figure 15: Moesin binds to MT1-, MT2- and MT3-MMP cytosolic tails. A) Diagram of the cytosolic residues 
of MT1-, MT2- and MT3-MMP. Positive amino acids are marked in red and serine residue is in blue. B) 
Binding of equal amounts of GST-fused moesin, N-terminus-moesin, C-terminus-moesin or GST alone was 
measured on microtiter plate wells coated with the indicated biotinylated peptides from MT-MMP cytosolic 
tails native or mutant sequences. Bound GST was detected using anti-GST antibody in an ELISA assay. 
Error bars represent standard error of the mean (SEM) from three independent experiments. C) Table of 
the native and mutant MT1-MMP cytosolic tail sequences used in the assays. Binding of equal amounts of 
GST fused N-terminus-moesin or GST alone was measured on microtiter plate wells coated with the 
indicated biotinylated peptides from MT1-MMP cytosolic tail native or mutant sequences. Bound GST was 
detected using anti-GST antibody in an ELISA assay. Error bars represent standard error of the mean 
(SEM) from three independent experiments.  
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For all mentioned before, it can be concluded that MT1-, MT2- and MT3-MMP bind in vitro to 
N-terminal domain of moesin. Moreover, the juxtamembrane polybasic cluster of MT1-MMP is a 
key region for its binding to moesin and MT1-MMP middle polybasic cluster also contributes to 
this binding.  
 
2.3. Analysis of MT1-MMP moesin binding in the cellular context 
 
      To analyze MT1-MMP interaction in the cellular context coimmunoprecipitation assays were 
performed. HUVEC lysates were precipitated with an MT1-MMP or an IgG control antibody and a 
western blot against moesin was performed. As it is depicted in Figure 16A, moesin 
coimmunoprecipitates with MT1-MMP but not with the IgG control. These preliminary data need to 
be confirmed.  
       
 
 
 
 
 
 
 
 
 
Figure 16: Analysis of MT1-MMP moesin binding in the cellular context. A) Moesin coimmunoprecipitates 
with MT1-MMP. HUVEC lysates were immunoprecipitated (IP) with MT1-MMP antibody or an IgG control. 
Immunoprecipitates and 5% of lysate (input) were resolved by SDS-PAGE and immunoblotted for moesin 
and MT1-MMP. B) MT1-MMP is increased in moesin-interfered cells. HUVEC were interfered with siRNA 
control or moesin siRNA. After 48, 72 or 96 cells were lysed and an SDS-PAGE was performed with 
equivalent protein amount of each condition. Afterwards, a western blot against MT1-MMP, moesin and 
tubulin was done. MT1-MMP corresponding bands were quantified (Image J) and normalized to tubulin 
ones. C) MT1-MMP is increased in the hydrophobic phase of moesin-interfered cells. HUVEC were 
interfered with an siRNA control or moesin siRNA. Cells were lysed and subcellular fractionation was 
performed. Aqueous and hydrophobic phase were analyzed by SDS-PAGE and western blot against MT1-
MMP, caveolin-1 and actin. Corresponding bands were quantified (Image J) and MT1-MMP/actin and MT1-
MMP/caveolin-1 ratios were calculated.  
B 
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      As moesin is a membrane linker of transmembrane proteins to actin cytoskeleton, we 
analyzed the effect of decreased moesin levels in MT1-MMP subcellular protein pools. Firstly, 
global MT1-MMP levels were checked. HUVEC were interfered for 48, 72 or 96h with 100nM or 
200nM of moesin siRNA or 200nM of control siRNA. Interestingly, MT1-MMP total protein level 
was increased correlating with the decrease of moesin in a dose dependent manner (Fig. 16B). 
Subsequently, we analyzed what MT1-MMP pool was increased in moesin-interfered cells. For 
this purpose, HUVEC control or moesin interfered cell lysates were subcellular fractionated with 
Triton X114 and MT1-MMP levels of the aqueous and hydrophobic phase were analyzed. As 
shown in Figure 16C, the increased MT1-MMP levels observed in the interfered cells are due to 
an increase of the MT1-MMP protein amount in the hydrophobic phase (caveolin-1-rich regions). 
These preliminary data require to be confirmed.  
 
3. Search of new molecular associations of MT-MMP cytosolic tails and 
analysis of their possible cellular function 
 
3.1. Search of new molecular associations of MT-MMP cytosolic tails 
 
To search for new molecular partners of MT-MMP cytosolic tails a proteomic approach was 
performed. Firstly, the cDNA corresponding to the cytosolic tails of MT1-, MT2-, MT3- and MT5-
MMP was directly cloned in pGEX-4T2 (Fig. 8 of Materials and Methods) to generate GST-MT-
MMPcyt fusion proteins that were used in pulldown assays with HMEC lysates. The obtained 
bands were excised from the gel and identified by MS in collaboration with the Proteomic Unit at 
CNIC. The proteins identified to interact with the MT-MMP cytosolic tails are listed in Figure 17A.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Next, to validate the candidate proteins obtained by MS, pulldown with the fusion proteins and 
western blot for some of the identified proteins was performed. No signal was obtained for 
annexin A1 and A2 binding to MT3-MMP by pulldown-WB (data not shown). Validation of ZO-1 
association with MT2-, MT3- and MT5-MMP was however obtained (Fig. 17B). Taking this into 
A  Candidate partners 
MT1-MMPcyt Vimentin 
MT2-MMPcyt 
ZO-1 
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Vimentin 
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ZO-1 
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Annexin A2 
β-tubulin 
MT5-MMPcyt ZO-1 ZO-2 
  B 
Figure 17: Identification of MT-MMP cytosolic tail candidate interacting proteins. A) Identified proteins 
associated with MT-MMP cytosolic tails. HMEC lysates were precipitated with GST or GST fused with MT1-, 
MT2-, MT3- and MT5-MMP cytosolic tails. Precipitates were run in a 10% SDS-PAGE and bands detected 
by Coomassie Blue staining were excised and identified by MS. B) Confirmation of ZO-1 association 
detected by MS. Lysates prepared from HUVEC were subjected to pulldown with the indicated GST or GST 
fusion proteins. The precipitates and 5% of lysate (input) were resolved by SDS-PAGE and immunoblotted 
for ZO-1. The immunoblot shown is representative of two experiments. 
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account, and the fact that ZO-1 contains 3 PDZ domains that are susceptible to bind to the PDZ 
binding motif of the MT-MMP cytosolic tails, we focus on ZO-1 for further analysis. 
 
3.2. MT2- and MT3-MMP interact directly with the N-terminus domain of ZO-1  
 
To characterize the interaction of MT2- and MT3-MMP with ZO-1, ELISA assays were 
performed. For this purpose, N-terminal domain of ZO-1, including its 3 PDZ domains, was used. 
This construct was added to streptavidin wells coated with the different biotinylated MT-MMP 
cytosolic tails (Fig. 10 of Materials and Methods). As it is depicted in Figure 18, we observed a 
direct binding of the cytosolic tails of MT2- and MT3-MMP to ZO-1. MT1-MMP could also bind to 
ZO-1 but much less efficiently than MT2- and MT3-MMP, according to MS and pulldown-WB 
results. 
 
 
 
 
 
 
 
 
 
 
 
Figure 18: Binding of N-terminus of ZO-1 (PDZ1-3) to MT1-, MT2- and MT3-MMP cytosolic tails. Binding of 
equal amounts of GST-fused ZO1-PDZ1-3 or GST alone was measured on microtiter plate wells coated with 
the indicated peptides corresponding to MT-MMP cytosolic tails. Bound GST was detected using anti-GST 
antibody in an ELISA assay. Error bars represent standard error of the mean (SEM) from five independent 
experiments.  
 
 
3.3. The three PDZ domains of ZO-1 bind MT2-MMP and MT3-MMP  
 
To discriminate which ZO-1 PDZ domains were responsible for the interaction with MT2- and 
MT3-MMP, fusion proteins of each of the three PDZ domains of ZO-1 with GST were used. As it 
is shown in Figure 19A the 3 PDZ domains of ZO-1 were able to bind to MT2- and MT3-MMP 
cytosolic tails, although PDZ3 presented less affinity. In the case of MT1-MMP, as expected, 
nearly no binding to any PDZ domain was detected. 
 
To deeper analyze MT2- and MT3-MMP interaction with ZO-1, the binding of the cytosolic 
tails of these MT-MMPs to PDZ2 of ZO-1 was also characterized by Surface Plasmon Resonance 
experiments (SPR) (Currie et al., 1999) in collaboration with Pascale Zimmerman and Ylva 
Ivarsson from the Faculty of Medicine, K.U.Leuven (Belgium). Biotinylated peptides 
corresponding to MT1-, MT2- and MT3-MMP cytosolic tails were coupled to the surface of the 
sensor chip and GST-ZO-1PDZ2 in solution was injected. In Figure 19B (left) the analysis of the 
concentration dependence of GST-ZO1PDZ2 for its binding to MT1-, MT2 and MT3-MMP 
cytosolic tails is depicted. From these curves, it was selected a concentration of 30 µM of GST-
ZO1PDZ2, close to saturation, for performing the following analysis. In Figure 19B (right) SPR 
measurements are shown. For this analysis the binding of ZO1PDZ2 to MT2-669∆V (data not 
shown) was used as a negative control and the values obtained for this peptide were substracted 
from MT2- and MT3-MMP results. MT2- and MT3-MMP binding to ZO-1 confirmed the previous 
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data obtained by ELISA and in the case of MT1-MMP very weak interaction with ZO-1PDZ2 was 
detected (data not shown).  
 
3.4. Analysis of the key residues of MT2-MMP involved in its binding to ZO-1  
 
As MT2-MMP has the closest cytosolic sequence to MT1-MMP (Fig. 4 of the Introduction) but 
it shows a different pattern regard to ZO-1 binding, we decided to focus on MT2-MMP and 
analyzed which amino acids of MT2-MMP cytosolic tail were responsible for its interaction with 
ZO-1. As MT2-MMP was binding to the PDZ domains of ZO-1 and it has a PDZ binding motif, the 
possibility that the five residues forming the PDZ binding motif were the ones responsible for the 
binding to ZO-1 arose as the most probable one. 
 
A PDZ domain consists of six β-strands (βA-βF) and two α-helices and peptide ligands have 
been seen to bind in an extended groove between strand βB and helix αB (Harrison, 1996). For 
this binding last residue of the PDZ binding motif, called P0, plays a key role (Harris and Lim, 
2001). Moreover, the side chain of the third residue of the PDZ binding motif starting from the C-
terminus, called P-2, directly points into the base of a second peptide-binding groove (Daniels et 
al., 1998) (Fig. 19C). Because of this, regarding what residue the ligand has at P-2 the affinity to 
different types of PDZ can be determined (Fig. 29 of the Discussion). 
 
To analyze the relevance of the P0 and P-2 residues in the interaction of MT2-MMP cytosolic 
tail and ZO-1, ELISA assays using MT2-MMP mutants were performed (Fig. 19D). As shown in 
Figure 19E, when last valine of MT2-MMP cytosolic tail was deleted no interaction with any of the 
PDZ domains of ZO-1 was detected. As P0 residue is essential for the peptide binding to PDZ 
domains, it can be concluded that MT2-MMP cytosolic tail is binding to the PDZ domains of ZO-1 
through its PDZ binding motif. However, no differences in binding were obtained when P-2 residue 
was mutated (MT2-MMP-E667A). 
 
Zhang and coll. analyzed in detail ZO-1PDZ1 and PDZ3 domain binding properties and their 
results revealed that not only P0 and P-2 residues were important for ligand recognition but also 
the penultimate residue of the ligand (P-1) (Zhang et al., 2006). Because of this we decided to 
explore the relevance of P-1 residue of MT2-MMP PDZ binding motif for the binding to ZO-1. By 
using MT2-MMPcyt-W668K and MT1-MMPcyt-K581W mutants we saw that, when lysine 581 of 
MT1-MMP was changed to a tryptophan, mimicking MT2-MMP cytosolic tail, MT1-MMP cytosolic 
tail was able to bind to the three PDZ domains of ZO-1. On the contrary, when the tryptophan 668 
of MT2-MMP was changed for a lysine, mimicking MT1-MMP cytosolic tail, interaction with ZO-1 
was abolished (Fig 19E). These results indicate that MT2-MMP tryptophan 668 is a key residue 
for its binding to ZO-1. 
 
To analyze if the behaviour of these residues was the same in a more physiological context in 
which other proteins are present and ZO-1 has its complete sequence, precipitation of HUVEC 
lysates with MT1- and MT2-MMP biotinylated cytosolic tails and their mutants was performed. As 
shown in Figure 19F, similar results to ELISA experiments were obtained.  
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                                                      PDZ binding motif 
Peptides used                                                             P-2 P-1 P0 
MT1-MMP 
MT1-K581W 
R R H G T P R R L L Y C Q R S  L L  D   K   V  
R R H G T P R R L L Y C Q R S  L L  D   W  V 
MT2-MMP 
MT2-669ΔV 
MT2-W668K 
MT2-E667A 
Q R K G A P R V L L Y C K R S  L Q  E   W  V 
Q R K G A P R V L L Y C K R S  L Q  E   W 
Q R K G A P R V L L Y C K R S  L Q  E   K   V 
Q R K G A P R V L L Y C K R S  L Q  A   W  V 
MT3-MMP K R K G T P R H  I L Y C K R S  M Q  E   W  V 
 
     C   D 
Figure 19: Molecular characterization of MT2-MMP and ZO-1 binding. A) Binding of equal amounts of GST 
fused ZO1-PDZ1, ZO1-PDZ2 and ZO1-PDZ3 or GST alone was measured on microtiter plate wells coated 
with the indicated peptides from MT-MMPs cytosolic tails. Bound GST was detected using anti-GST 
antibody in an ELISA assay. Error bars represent standard error of the mean (SEM) from three 
independent experiments. B) ZO-1 PDZ2 domain interacts with MT2- and MT3-MMP in SPR experiments. 
Left: purified GST-ZO1PDZ2 was perfused at different concentrations over a sensorchip coated with MT1-, 
MT2- and MT3-MMPcyt biotinylated peptides. Concentration dependence of GST-ZO1PDZ2 for its binding 
to the peptides was measured.  Right: purified GST-ZO1PDZ2 was perfused at 30µM over a sensorchip 
coated with biotinylated peptides of MT2-MMP, MT2-MMP-669∆V and MT3-MMP cytosolic tails. Values 
correspond to response units (RU) measured 4 minutes after perfusion of the protein. For negative control 
MT2-MMP-669∆V was used and the values obtained for this peptide were subtracted (n=2). C) Diagram of 
a PDZ domain (PSD-95 PDZ domain 3) with a bound peptide (NH2-KQTSV-COOH, shown in blue). The 
side chains of the peptide P0 residue (valine) and P-2 residue (threonine) are shown in stick form, as is the 
terminal carboxylate (Doyle et al., 1996). D) Diagram of native and mutant MT-MMP cytosolic tails used in 
the assays. E) Binding of equal amounts of GST fused ZO1-PDZ1, ZO1-PDZ2 and ZO1-PDZ3 or GST 
alone was measured on microtiter plate wells coated with the indicated peptides from MT-MMP mutant 
cytosolic tails. Bound GST was detected using anti-GST antibody in an ELISA assay. Error bars represent 
standard error of the mean (SEM) from three independent experiments. F) Lysates prepared from HUVEC 
were subjected to precipitation with the indicated biotinylated peptides. Precipitates and 5% of lysate 
(input) were resolved by SDS-PAGE and immunoblotted for ZO-1. The immunoblot shown is 
representative of two experiments. 
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Based in all these results it can be concluded that MT2-MMP and MT3-MMP bind through 
their PDZ binding motif to the three PDZ domains of ZO-1, although with higher affinity for PDZ1 
and PDZ2. In the PDZ binding motif the tryptophan 668 of MT2-MMP is essential for the 
interaction and it is the responsible of the different affinity of MT1-MMP and MT2-MMP for ZO-1.  
 
3.5. Analysis of MT2-MMP/ZO-1 association in the cellular context 
 
To confirm the interaction between MT2-MMP and ZO-1 in the cellular context, we expressed 
MT1-MMP-HA or MT2-MMP-HAFlag constructs in HeLa cells. These proteins were 
immunoprecipitated with HA antibody and the immunoprecipitates were resolved by SDS-PAGE. 
Immunoblotting analysis demonstrated that ZO-1 coimmunoprecipitates with MT2-MMP but not 
with MT1-MMP (Fig. 21A).   
 
To analyze the importance of the tryptophan of MT2-MMP PDZ binding motif in its binding to 
ZO-1 in the cellular context, we expressed MT1-MMP-HAK581W and MT2-MMPHAFlag-W668K 
constructs in epithelial HeLa cells. These proteins were immunoprecipitated with HA antibody and 
the immunoprecipitates were resolved by SDS-PAGE. Immunoblotting analysis demonstrated that 
MT2-MMP 668 tryptophan is essential for MT2-MMP and ZO-1 coimmunoprecipitation. When this 
tryptophan is not present, MT2-MMP cytosolic tail interaction with ZO-1 is significantly decreased 
(Fig. 20B). 
      MT2-MMP/ZO-1 association was also analyzed by immunofluorescence in a model of 
transformed epithelial cells (breast carcinoma cell line MDA-MB-231) that express high levels of 
endogenous MT2-MMP, since MT2-MMP antibodies do not display high affinity. Firstly, MT2-
MMP and F-actin double staining was performed. As it can be seen in Figure 21A, MT2-MMP is 
localized in cell protrusions. Double staining of MT2-MMP and ZO-1 shows that these two 
proteins colocalize in lamellipodia and in the perinuclear region of these cells (Fig. 21B). 
Figure 20: ZO-1 coimmunoprecipitates with MT2-MMP but not with MT1-MMP. Tryptophan 668 of MT2-
MMP cytosolic tail is essential for MT2-MMP and ZO-1 coimmunoprecipitation. A) Lysates of HeLa non 
transfected or ectopically expressing MT1-MMP-HA or MT2-MMP-HAFlag were immunoprecipitated (IP) 
with HA antibody and blotted for ZO-1 and HA. The immunoblot shown is representative of two 
experiments. B) Lysates of HeLa cells transfected with the empty vector (Mock) or ectopically expressing 
MT1-MMP-HA (MT1H), MT1-MMP-HA-W581K (MT1H-WK), MT2-MMP-HAFlag (MT2HF) or MT2-MMP-
HAFlag-W668K (MT2HF-WK) were IP with HA antibody and blotted for ZO-1 and HA. The immunoblot 
shown is representative of two experiments.   
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3.6. Search for a proper cell model to analyze MT2-MMP/ZO-1 interaction  
 
      MT2-MMP is not as well characterized as other metalloproteinases such as MT1-MMP. We 
then first analyzed and compared its expression and cell localization in several primary and tumor 
cells to search for a good model to study MT2-MMP/ZO-1 interaction in a physiological scenario. 
As it is depicted in Figure 22, two endothelial primary cell types were analyzed; human umbilical 
endothelial cells (HUVEC) and bovine aortic endothelial cells (BAEC). In the case of HUVEC 
MT2-MMP expression was detected by PCR (Fig. 22A). However, neither in HUVEC nor in BAEC 
MT2-MMP protein could be detected by western blot (data not shown) or immunofluorescence 
(Fig. 22B). Lung cancer cells, H460 (human epithelial large lung cancer cell line) and H441 
(human lung adenocarcinoma epithelial cell line), were also analyzed; despite the fact that in both 
cell types MT2-MMP expression was detected by PCR, MT2-MMP protein staining was faint or 
diffuse (Fig. 22B). 
 
 
Figure 21: MT2-MMP and ZO-1 colocalize in breast cancer cells (MDA-MD-231). A) Image of cells stained 
for MT2-MMP (green) and F-actin (red). In the botton panels a cell protrusion detail is shown. Scale bar 
10μm. B) Image of cells stained for MT2-MMP (green) and ZO-1 (red). Nuclei were stained with Hoescht 
33342 (blue). MT2-MMP and ZO-1 colocalize at the cell lamella and in the perinuclear region. Scale bar 
10μm. 
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Taking into account the difficulty to detect and analyze subcellular localization of endogenous 
MT2-MMP in primary cells, and the fact that MT2-MMP is higher expressed in tumor epithelial 
cells and in epithelial tissues during development (Rebustini et al., 2009), we moved to analyze 
MT2-MMP/ZO-1 interaction in the epithelial context. For this purpose, Madin-Darby Canine 
Kidney cells (MDCK), a commonly used non-transformed epithelial cell line, were selected. Stable 
clones expressing MT1-MMP-HA, MT1-MMP-KW-HA, MT2-MMP-HAFlag, MT2-MMP-WK-HAFlag 
or transfected with the empty vector (Mock) were selected and checked for MT-MMP expression 
by immunofluorescence (Fig. 23A) and western blot (Fig. 23B). 
 
Figure 22: MT2-MMP expression and cellular localization in primary and transformed cells. A) Summary of 
the analysis of MT2-MMP expression (RT-PCR) and subcellular localization (immunoflourescence) in 
primary cells (HUVEC and BAEC), lung cancer cells (H460 and H441) and breast cancer cells (MDA-MB-
231). B) Images of cells stained for MT2-MMP (green) are shown. Nuclei were stained with Hoescht 33342 
(blue). Scale bar 10μm. 
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3.7. Cyst formation is not affected by MT2-MMP expression 
 
      Most internal epithelial organs consist of a monolayer of epithelial cells surrounding a central 
lumen. As MT2-MMP localization and function has been previously analyzed in 3D models and 
tissue explants, and MT2-MMP has been involved in submandibular gland development (Hotary 
et al., 2000; Rebustini et al., 2009), a possible role of MT2-MMP in the formation of three 
dimensional structures was first analyzed. For this purpose in vitro MDCK cyst formation was 
selected as a model. Formed cysts were counted and no differences were founded in the number 
of cyst formed by MDCK cells or MDCK cells expressing MT2-MMP.  
 
      Afterwards, cysts were stained for F-actin and Ezrin to check for correct apico-basal polarity of 
the cells forming the cyst, as these are two apical markers (Kivela et al., 2000). As it is depicted in 
Figure 24A, MT2-MMP-MDCK cells forming the cysts display an apical F-actin and ezrin 
distribution as the MDCK control cells. Moreover, the number of lumens per cyst were counted as 
it can also indicate aberrant polarization of the cells (Martin-Belmonte et al., 2008). We did not 
observe changes in MT2-MMP-MDCK cysts compared with control ones (677 cysts of Mock-
MDCK and 680 cysts of MT2-MMP-MDCK were counted) (Fig. 24B).  
 
 
 
 
     HA 
                    Mock                  MT1-HA           MT1-HA-KW       MT2-HAFlag      MT2-HAFlagWK       A 
         B 
HA
 MT1 
 MT2 
Figure 23: MDCK stable transfectant clone generation. MDCK cells were transfected with pCR3.1 empty 
vector (mock) or pCR3.1 containg each of the following tagged cDNA inserts: MT1-MMP-HA, MT1-MMP-
KW-HA, MT2-MMP-HAFlag, MT2-MMP-WK-HAFlag. Transfected MDCK cells were cultured in the 
presence of 400 µg/ml of G418 and single cell colony selection was performed by limited cell dilution in 96-
well plates. A) MT-MMP localization in stable transfectants. In each of the clones the corresponding MT-
MMP levels was checked by immunoflourescence. B) MT-MMP protein expression in each clone was also 
checked by western blot analysis.  
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3.8. MT2-MMP colocalizes with ZO-1 in polarized MDCK cells 
 
      Cyst formation involves many cellular functions besides cellular polarity such as migration, 
proliferation and apoptosis (Bryant and Mostov, 2008). Because of this we decided to move to a 
simpler model; MDCK polarized cells. When MDCK cells are cultured on transwell filters they get 
polarized mimicking a physiological scenario for an epithelial monolayer context. Firstly, MT2-
MMP and ZO-1 localization was checked. As it can be seen in Figure 25A, MT2-MMP colocalizes 
with ZO-1 near the apical junctions (Maenders coefficient 0.51). MT2-MMP-WK mutant, unable to 
B 
Figure 24: Cyst formation by MDCK control cells (Mock) and MT2-MMP-MDCK expressing cells. A) Mock 
and MT2-MMP-MDCK formed cysts were stained for ezrin and F-actin (Phalloidin-Texas Red). Pictures of 
cyst sections are shown. B) Percentage of cysts with 0, 1 or 2 lumens was calculated (677 cysts of Mock-
MDCK and 680 cysts of MT2-MMP-MDCK from 2 independent experiments were counted). 
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bind to ZO-1, colocalizes with ZO-1 at the junctions at lower extent (Maenders coefficient 0.45) 
(Fig. 25B). 
 
 
 
 
 
 
 
 
 
 
 
 
3.9. MT2-MMP, but not MT2-MMP-WK, affects F-actin polarization of MDCK epithelial 
monolayers 
 
      In epithelial cells the cytoskeleton plays an important role in the generation and maintenance 
of the polarized phenotype. In this regard, apical F-actin has been shown to play a role in 
maintaining the apical localization of certain proteins in MDCK cells, even in the absence of cell-
cell contacts (Ojakian and Schwimmer, 1988). As MT2-MMP was localized together with ZO-1 in 
cell-cell junctions, we next checked apical-basal F-actin in these MT2-MMP-MDCK cells. As 
shown in Figure 26, MDCK get polarized when cultured in transwell filters and a clear pattern of 
          B 
Figure 25: MT2-MMP, MT2-MMPWK and ZO-1 localization in MDCK polarized cells. MDCK cells were 
cultured on transwell filters (Costar). After 3-5 days cells were fixed and stained for HA (MT2-MMP) (green) 
and ZO-1 (red). A) MT2-MMP colocalizes with ZO-1 in the apical junctions of MDCK polarized cells (yellow). 
Top panels: XY axis. Bottom panels: XZ axis. B) In MT2-MMP-WK MDCK cells MT2-MMP colocalizes with 
ZO-1 at lower extent. Upper panels: XY axis. Bottom panels: XZ axis. A: Apical, B: basal. 
        HA (MT2-MMP-WK)                      ZO-1                               Merge 
      A           HA (MT2-MMP)                      ZO-1                               Merge 
   Merge
 ZO-1
HA  
(MT2-MMP) 
A 
B 
A 
B 
A 
B 
HA  
(MT2-WK) 
   ZO-1
      Merge
A 
B 
A 
B 
A 
B 
Results 
 
 68
apical (cortical actin), medium (cell-cell contacts) and basal (stress fibers) actin filaments can be 
distinguished.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26: MT2-MMP, but not MT2-MMP-WK, affects F-actin apical-basal distribution. MDCK cells 
were cultured on transwell filters. After 3-5 days cells were fixed and stained for F-actin with Phalloidin-
Texas Red. A) Pictures of XY axis corresponding to the apical, medium and basal regions of Mock, 
MT2-MMP and MT2-MMP-WK polarized monolayer. B) XZ axis of pictures in A. Histogram shows 
apical/basal F-actin ratio quantified with Image J (n=3). A: Apical, B: basal. 
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      In the case of MT2-MMP, but not MT2-MMP-WK, basal actin filaments were less organized 
(Fig. 26A). To further analyze this observed difference in actin organization, F-actin apico/basal 
ratio was measured. In the case of the control MDCK cells (Mock) and MT2-MMP-WK cells, F-
actin is mainly located in the apical compartment. On the contrary, in MT2-MMP MDCK cells the 
ratio between apical and basal F-actin is decreased, indicating that F-actin is less polarized. 
Moreover, F-actin pattern at cell junctions seemed less organized in MT2-MMP expressing cells 
compared with Mock or MT2-MMP-WK MDCK (Fig. 26B). 
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1. Binding of the MT1-MMP cytosolic tail to p130Cas is involved in its regulation 
of myeloid progenitor fusion 
 
The function of MT1-MMP cytosolic tail in migration and invasion is unclear and complex 
(Lehti et al., 2000; Sabeh et al., 2004). A potential problem is that many studies have used MT1-
MMP mutants with the whole cytosolic tail deleted, thus removing putative positive and negative 
regulatory elements. This led to contradictory findings, with the cytosolic tail apparently 
dispensable for the catalytic activity of MT1-MMP in 3D contexts (Sabeh et al., 2004), while partial 
deletion mutants (Δ567 and Δ573) pointed to these sequences as important for MT1-MMP 
localization at the leading edge for Matrigel invasion (Lehti et al., 2000). Our findings clearly show 
the mechanism by which the MT1-MMP cytosolic tail contributes to myeloid cell fusion. In 
particular, our results show that the phosphorylation of Tyr573 is important for the association of 
MT1-MMP with p130Cas, an issue not addressed previously. Interestingly, MT1-MMP-Tyr573 can 
be phosphorylated by Src kinase (Nyalendo et al., 2007), which is essential for normal OC 
development (Soriano et al., 1991). We also show that MT1-MMP-p130Cas association is 
important for optimal membrane targeting and activity of Rac1 in myeloid progenitors. It seems 
that MT1-MMP, like integrins, is important for the proper regulation of GTPases in distinct 
contexts: MT1-MMP cooperates with Cdc42 in the formation of tunnels for invasion within 3D 
matrices (Fisher et al., 2009), the MT1-MMP cytosolic tail can bind p27RF-Rho, a regulator of 
RhoA activity, and MT1-MMP deficiency decreases the amounts of Rac1 and Cdc42 and 
increases RhoA activity at the lamellipodia of myeloid progenitors (reviewed in(Gonzalo and 
Arroyo, 2010).   
 
Our results suggest a model (Fig. 27) in which MT1-MMP at the membrane of BM myeloid 
progenitors contributes to the efficient recruitment and activation of the p130Cas-Rac1 complex at 
lamellipodia. MT1-MMP is likely associated with by integrins at these sites. Among them, αvβ3 
can be the integrin implicated in this process as it has been seen that MT1-MMP can be 
associated to αvβ3 in MT1-MMP protrusions (Galvez et al., 2002; Galvez et al., 2004). In such 
localization MT1-MMP would be phosphorylated in the tyrosine 573 of its cytosolic tail by Src 
kinases and this phosphorylation would contribute to the increase p130Cas and Rac1 targeting. 
p130Cas has 15 YxxP motifs in its substrate domain that can be phosphorylated (Fig. 5 of the 
Introduction). Binding of p130Cas to MT1-MMP might favour the phosphorylation of p130Cas at 
these sites. This phosphorylation would lead to Crk recruitment and then to Rac activation (Birge 
et al., 2009). Impairment of this signaling pathway in the absence of MT1-MMP would decrease 
lamellipodia activity and cell migration, resulting in inefficient cell fusion.  
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Figure 27: MT1-MMP is a novel component of the macrophage fusion machinery. The MT1-MMP 
cytosolic tail binds to the adaptor protein p130Cas thus contributing to optimal Rac1 membrane 
targeting and activity in myeloid progenitors. MT1-MMP tyrosine 573 is relevant to its association with 
p130Cas and it has been previously reported to be phosphorylated by Src kinase (Nyalendo et al., 
2007) (Taken from Gonzalo and Arroyo, 2010). 
 
 
2. Moesin binds MT1-, MT2- and MT3-MMP cytosolic tails 
 
2.1. Analysis of MT1-, MT2- and MT3-MMP moesin binding 
 
The obtained MT1-MMP-moesin binding pattern is similar to the ones obtained by other 
authors. Ivetic and coll. analyzed in detail the binding of ERM proteins to L-selectin, a cell 
adhesion molecule that is expressed exclusively in leukocytes. L-selectin has three polybasic 
clusters and a fourth positive residue located near the C-terminus (Table 4). By mutating one 
positive residue of each polybasic cluster of L-selectin, this group saw that only when the arginine 
of the juxtamembrane polybasic region was mutated, a reduced binding to ERMs was obtained 
(Ivetic et al., 2002). In other study, Serrador and coll. analyzed moesin binding to the intercellular 
adhesion molecule 3 (ICAM-3), a leukocyte-specific receptor involved in primary immune 
responses. They saw that the histidine and the second arginine of the juxtamembrane polybasic 
cluster of ICAM-3 (Table 4) were important for its binding to moesin because when these two 
residues were together mutated the interaction with moesin was significantly reduced (Serrador et 
al., 2002b).  
 
 In our study MT1-MMP seems to follow the same behaviour as L-selectin and ICAM-3. 
Taking also in to account the fact that MT2-MMP also binds to moesin and it lacks the first residue 
of the juxtamembrane polybasic cluster, it can be speculated that the second arginine and the 
histidine residue of the juxtamembrane polybasic cluster of MT1-MMP are the key residues 
involved in MT1-MMP binding to moesin. 
 
The importance of serine motifs for ERM binding to transmembrane proteins has also been 
analyzed. P-selectin glycoprotein ligand 1 (PSGL-1) (Table 4), an adhesion receptor involved in 
the rolling of neutrophils on activated endothelium, has been seen to bind moesin. For this 
interaction just the juxtamembrane region of the cytosolic tail of PSGL-1 was sufficient (18 aa). By 
performing point mutations it has been reported an important role of the two first serines of  
PSGL-1 for its binding to moesin (and in the importance of the juxtamembrane positive cluster as 
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in the case of L-selectin and ICAM-3) (Serrador et al., 2002a). The role of serine rich motifs of 
ICAM-3 for its binding to moesin has also been reported. Serrador and coll. determined that the 
serine residues of ICAM-3 are needed in its interaction with moesin and ezrin. They analyzed by 
single point mutations the fourth serines of ICAM-3; when each of the three first serines was 
changed to an alanine, reduced binding to moesin was obtained. However, when the fourth serine 
was mutated, a slightly increase of moesin binding was detected (Serrador et al., 2002b). In our 
results, no decrease of N-moesin binding was obtained when MT1-MMP serine was mutated, 
thus it seems that this serine does not contribute to the regulation of the binding. We have to take 
into account that in the case of MT1-MMP there is only one serine and not a cluster as in PSGL-1. 
But we can not discard the possibility that this serine could have a role in the case of MT2- and 
MT3-MMP, because these proteins have partially the same sequence of PSGL-1 but in the 
opposite order (KRS) and they have a cluster (and not just one as MT1-MMP) of positive residues 
close to the serine for the binding of transmembrane proteins to ERMs.   
 
                    Table 4: Cytosolic residues of MT1-, MT2-, MT3- and the proteins associated to  
                    ERMs commented in the discussion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                  Positive residues are highlighted in red. Serine residues are highlighted in blue.  
     Mutated residues are underlined. 
 
In regard to MT3-MMP, more than 2-fold affinity for moesin in comparison with MT1- or MT2-
MMP was detected. MT1- and MT3-MMP have both three juxtamembrane positive residues that 
as we have mentioned are essential for MT1-MMP/moesin interaction. There are not relevant 
differences in the sequence of MT3-MMP that can allow us to speculate why this increased 
affinity is obtained. We can hypothesize that probably this difference can be due to the 
accumulation of positive residue clusters. MT3-MMP has three positive clusters and, on the 
contrary, MT1- and MT2-MMP have only two.  
 
2.2. MT1-MMP binding to moesin could link MT1-MMP to actin cytoskeleton and affect its 
internalization 
 
When cells migrate they localize MT1-MMP at lamellipodia, the migration front of the cells, to 
degrade ECM barrier (Itoh et al., 2001; Sato et al., 1997). This localization was thought to be due 
to the interaction of MT1-MMP with CD44 through the hemopexin domain of the enzyme and 
stem region of CD44. CD44 in turn is associated with F-actin through its cytoplasmic domain by 
interacting with ERM proteins. Then, by this interaction, MT1-MMP is indirectly associated with F-
MT-MMP Cytosolic residues 
MT1-MMP RRHGTPRRLLYCQRSLLDKV 
MT2-MMP QRKGAPRVLLYCKRSLQEWV 
MT3-MMP KRKGTPRHILYCKRSMQEWV 
Transmembrane 
protein Cytosolic residues 
L-selectin RRLKKGKKSQERMDDPY 
ICAM-3 REHQRSGSYHVREESTYLPLTSMQPTEAMGEEPSRAE 
PSGL-1 RLSRKGHMYPVRNYSPTEMVCISSLLPDGGEGPSATANGGLSKAKSPGLTPEPREDREGDDLTLHSFLP 
Discussion 
 
 76
actin (Mori et al., 2002). Without excluding this possibility, we propose that MT1-MMP could also 
be linked to the actin cytoskeleton though its direct binding to ERM proteins (Fig. 28). More 
experiments are needed to verify this point.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28: MT1-MMP is regulated by its association with CD44 followed by localization to migration front. 
Homodimers of MT1-MMP interact with CD44, which is bound to the actin cytoskeleton though the ERM 
proteins (Mori et al., 2002). Binding of MT1-MMP to actin cytoskeleton through its binding to ERMs can be 
also expected. 
 
This link to F-actin might regulate MT1-MMP localization. In this regard, our preliminary 
results point to a role of moesin in the regulation of MT1-MMP membrane pool. It can be thought 
that moesin could be affecting MT1-MMP recycling and in this way decrease of moesin levels will 
lead to MT1-MMP membrane accumulation. It has been seen that the cortical cytoskeleton 
regulates the membrane localization of several adhesion receptors, such as ICAMs, VCAM-1, 
CD43 and CD44, though ERM proteins (Barreiro et al., 2002; Heiska et al., 1998; Serrador et al., 
1997; Yonemura et al., 1998). For example, transfection of human ezrin into natural killer resistant 
cells induces the redistribution of ICAM-2 (Helander et al., 1996).  
 
3. ZO-1 is a novel interacting partner of MT2-MMP cytosolic tail 
 
3.1. MT2-, MT3- and MT5-MMP interact with ZO-1  
 
      Interaction with ZO-1 was detected for MT2-, MT3- and MT5-MMP, but not for MT1-MMP. 
Specifically, the cytosolic tail of these metalloproteinases could bind to each of the three PDZ 
domains of ZO-1. However, MT2- and MT3-MMP did not show the same affinity for the different 
PDZ domains of ZO-1. ZO-1 PDZ2 presented the highest binding to the metalloproteinases 
followed by PDZ1, and PDZ3 clearly showed the least binding to MT2- and MT3-MMP. Zhang and 
coll. observed that ZO1-PDZ3 had more affinity for leucine ending ligands and, in contrast, ZO1-
PDZ1 preferentially bound to proteins ending in a valine residue (Zhang et al., 2006). As MT2- 
and MT3-MMP cytosolic tail terminal residue is a valine, these different binding preferences of 
ZO-1 PDZ domains can be the factor by which these metalloproteinases have less affinity for 
ZO1-PDZ3.  
 
      MT5-MMP has been previously described to bind to the PDZ domains of two proteins; Mint-3 
(Wang et al., 2004a) and ABP (Monea et al., 2006). Mint-3 contains two PDZ domains and 
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mutants lacking each PDZ domain remain associated with MT5-MMP, indicating that either of the 
PDZ domains is sufficient for binding MT5-MMP. Among the seven PDZ domains of ABP, MT5-
MMP has been seen to bind to PDZ5, however PDZ4 acted as an accessory domain, which 
contributed to the generation of a compact, two PDZ domain structure; PDZ4-5. In this structure, 
PDZ5 provided the single functional binding site, and PDZ4 stabilized PDZ5 (Feng et al., 2003).       
In our studies a higher interaction of MT2- and MT3-MMP cytosolic tails with ZO-1 N-terminus 
(PDZ1-3) compared with the single ZO-1 PDZ domains was detected. This suggests that, despite 
the fact that MT2- and MT3-MMP are able to bind to each of the three PDZ domains of ZO-1, the 
presence of the complete ZO-1 N-terminal domain positively modulates this binding. These 
observations point to a cooperative interaction of the different ZO-1 PDZ domains as in the case 
of ABP with MT5-MMP (Monea et al., 2006). Moreover, when cell lysate precipitation or in vitro 
assays with ZO-1 N-terminus were performed, similar binding of ZO-1 to MT2- and MT3-MMP 
was obtained. In contrast, MT3-MMP showed more affinity than MT2-MMP when single PDZ 
domains of ZO-1 were used. Again, these results indicate the possible existence of a regulatory 
affinity mechanism included in ZO-1 N-terminus.  
 
3.2. MT2-MMP binds to ZO-1 through its PDZ binding motif 
 
Extensive peptide library screens pioneered by Songyang and coll. revealed the specificities 
of distinct PDZ domains (Schultz et al., 1998; Songyang et al., 1997). Together, their results 
suggested that PDZ domains were extremely selective and, as it has been commented, P0 and  
P-2 residues of the PDZ binding motifs were identified as the most critical residues for PDZ 
domain recognition. Therefore, PDZ domains can be divided into three main classes on the basis 
of their preferences for residues at P0 and P-2. Class I PDZ domains recognize the motif S/T-X-
V/L (where X is any amino acid), class II domains recognize the motif Φ-X-Φ (where Φ is a 
hydrophobic amino acid) and class III domains recognize the motif D/E-X-Φ (Table 5) (Nourry et 
al., 2003).  
 
  Table 5: PDZ domain classification (adapted from(Nourry et al., 2003). 
PDZ Domain 
Consensus 
binding 
sequence 
Ligand protein Reference 
 
Class I 
     Syntrophin 
     PSD-95 
     P-2  P-1  P0 
S/T   X   V/L 
S     L    V 
T     D    V 
 
 
Voltage-gated Na+ channel 
Shaker-type K+ channel 
 
 
(Schultz et al., 1998) 
(Kim et al., 1995) 
Class II 
     hCASK 
     Erythrocyte p55 
Φ    X    Φ 
Y     Y    V 
Y     F     I 
 
Neurexin 
Glycophorin C 
 
(Songyang et al., 1997) 
(Marfatia et al., 2000) 
Class III 
     nNOS 
     Mint-1    
     D/E  X    Φ  
       D    S    V 
       E     P    L 
 
Melatonin receptor 
KIF17 
 
(Stricker et al., 1997) 
(Setou et al., 2000) 
    X denotes any amino acid (no specificity defined at this position for this class) 
   Φ denotes a hydrophobic amino acid, usually V, I or L 
 
      Based in this classification, C-terminal sequence of MT-MMPs, DKV in MT1-MMP and EWV in 
MT2-, MT3- and MT5-MMP, are typical Class III PDZ domain binding proteins. Consistently with 
Mint-3 and MT5-MMP binding (Wang et al., 2004a), Mint proteins belong to Class III PDZ 
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domains, and both of their PDZ domains can recognize Class III PDZ motifs (Setou et al., 2000). 
Subsequently, Bezprozvanny and Maximov proposed a novel classification of PDZ domains 
based on the nature of the amino acids in the two critical positions of the PDZ domain fold 
previously suggested to account for specificity of P-1 and P-2 positions of the PDZ binding motif 
(Daniels et al., 1998). Their classification divided PDZ domains into 25 groups. Interestingly, ZO-1 
and ZO-2, but not ZO-3, belonged to the same group as GRIP, which has been seen to bind MT5-
MMP cytosolic tail (Bezprozvanny and Maximov, 2001). 
 
      Detailed in vitro analysis of ZO1-PDZ1 and PDZ3 domain binding properties using synthetic 
peptides was later performed by Zhang and coll. (Zhang et al., 2006). Their results revealed the 
importance of all the C-terminal residues of the ligand, and not only P0 and P-2 residues, for PDZ 
binding recognition. Interestingly, the results of this group highlighted the importance of P-1 of the 
PDZ binding motif. PDZ-1 and PDZ-3 of ZO-1 were found to accept tryptophan or tyrosine in P-1 
position. Moreover, the binding affinity of a synthetic peptide when P-1 tryptophan was substituted 
for each of the rest amino acids was checked. For all the substitutions, except tyrosine, a great 
reduction in the binding was obtained (Zhang et al., 2006). Among the combinations tryptophan 
substitution for a lysine, as we performed in MT2-MMP cytosolic tail, was included. 
 
      Finally, regarding P-2 residue, no preference was detected for ZO1-PDZ3. On the contrary, 
ZO1-PDZ1 exhibited class I binding specificity, as this domain preferentially bound to ligands with 
Thr/Ser at position P-2 (Zhang et al., 2006). Our data shows that, despite the fact that neither 
MT2-, MT3- nor MT5-MMP have Thr/Ser at this position, they are able to interact with ZO1-PDZ1. 
Moreover, we showed that this position did not play a key role for ZO-1 binding because when it 
was substituted for an alanine the interaction with ZO-1 was maintained. 
 
      Regarding ZO-1 interactions with natural ligands, ZO1-PDZ domains have been shown to 
interact with several proteins, including members of the large families of claudins (Ikari et al., 
2004), connexins (Kausalya et al., 2001; Laing et al., 2001) and also the ZO-1 homologues ZO-2 
and ZO-3 (Wittchen et al., 1999) (Fig. 30). ZO1-PDZ1 is responsible for interactions with 
members of the claudin family. Claudin C-termini, are atypical type I PDZ ligands as they do not 
contain the defining Thr/Ser at P-2. In fact, P-2 is remarkably diverse among their sequences. This 
is another example that, although the consensus binding sequence of ZO-1 PDZ1 is described to 
correspond to class I, other PDZ binding motifs that do not belong to PDZ class I can be also 
partners of ZO-1. Moreover, regarding P-1, nearly all of the 20 described claudin proteins present 
a tyrosine at this position. As we have commented tyrosine and tryptophan were described to be 
important for ZO1-PDZ1 binding affinity (Zhang et al., 2006).  
 
      Taking together the identification of P-1 tyrosine and tryptophan as important players for ZO1-
PDZ1 binding using synthetic peptides (Zhang et al., 2006), the high degree of conservation of 
the tyrosine residue of claudins at this position (Ikari et al., 2004) and the key role of P-1 
tryptophan for MT2-MMP binding to ZO-1 that we have described in this work; it can be 
suggested that P-1 can be the key player for determining the ligand affinity for ZO-1 PDZ domains. 
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3.3. MT2-MMP/ZO-1 association affects F-actin polarization of epithelial monolayers  
 
      Our data show that MT2-MMP colocalizes with ZO-1 at cell-cell contacts of polarized epithelial 
MDCK cells. Moreover, MT2-MMP expressing cells, but not the ones expressing MT2-MMP-WK 
that is unable to bind to ZO-1, present a decreased F-actin apical polarization. These data point to 
a possible role of MT2-MMP in apical-basal polarity of these cells by its association with ZO-1. 
However, although the establishing of apico-basal polarity is important for MDCK cyst formation 
(Martin-Belmonte et al., 2008), no differences in the number of cyst nor in the number of lumens 
of the cyst were observed in MT2-MMP-MDCK expressing cells compared with control ones. For 
cyst formation different events have to take place and in addition to polarization, cell proliferation 
and apoptosis play also an important role. It has been proposed that when the acquisition of 
polarity is efficiently achieved and coordinated with cell proliferation, lumen formation occurs 
without requirement of apoptosis. However, when apico-basal polarization is slow or inefficient or 
when cell polarity is uncoordinated with cell proliferation, apoptosis of cells becomes essential 
(Martin-Belmonte et al., 2008). Thus, other mechanisms such as apoptosis can be compensating 
a possible defect in apico-basal polarity of these cells. 
 
Cell polarity involves the asymmetric organization of most of the physical aspects of the cell, 
including the cell surface, intracellular organelles and the cytoskeleton. In an epithelial polarized 
tissue the apical surfaces of the cells provide the luminal interface and are specialized in 
regulating the exchange of materials. The lateral surfaces of epithelial cells contact adjacent cells 
and have specialized junctions and cell-cell adhesion structures. The basal surfaces of these cells 
contact the underlying basement membrane, ECM and, ultimately, underlying blood vessels. The 
basal and lateral surfaces are fairly similar in composition and organization, and are often referred 
together as the basolateral surface. The apical and basolateral surfaces, however, have very 
different compositions. In the maintenance of these differences, TJ play a key role (Bryant and 
Mostov, 2008).  
 
TJ are found at the most-apical portion of the lateral surfaces, where they form barriers both 
between the apical and basolateral surfaces and between adjacent cells, limiting paracellular 
permeability. These junctions have an organizing role in epithelial polarization and establish an 
apico-lateral barrier to the diffusion of solutes through the intracellular space (gate function). They 
also restrict the movement of lipids and membrane proteins between the apical and the 
basolateral membrane (fence function). TJ are highly ordered membrane contact sites or ‘kissing 
points’, comprising a network of intra-membrane proteins (Aijaz et al., 2006). They comprise at 
least four types of transmembrane proteins, including occludins, claudins, junctional adhesion 
molecules (JAMs) and crumb, and a number of cytoplasmic peripheral proteins. Whereas the 
transmembrane proteins mediate cell-cell adhesion, the cytosolic TJ plaque contains various 
types of proteins that link TJ transmembrane proteins to the underlying cytoskeleton. These 
adapters also recruit regulatory proteins, such as protein kinases, phosphatases, small GTPases 
and transcription factors, to the TJ. As a result, structural (actin and spectrin) and regulatory 
(actin-binding proteins, GTPases and kinases) proteins are juxtaposed with transmembrane 
proteins. This protein scaffolding facilitates the assembly of highly ordered structures, such as 
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junctional complexes or signaling patches that regulate epithelial cell polarity, proliferation and 
differentiation (Matter et al., 2005) (Fig. 29). 
 
ZO-1 is localized in these TJ plaque structures and it has an important role in creating and 
maintaining specialized membrane domains. Though its PDZ domains (Fig. 7 of the Introduction) 
ZO-1 binds to C-terminal ends of various proteins, especially transmembrane proteins. Thus, it 
can cross-link these transmembrane proteins at the cytoplasmic surface of plasma membranes to 
establish these specialized membrane domains (Fig. 29) (McNeil et al., 2006). 
 
One of these transmembrane proteins involved in TJs are claudins (Fig. 29A). Claudins 
appear to be involved in the homophilic and/or heterophilic interactions implicated in cell-cell 
adhesions. They have four hydrophobic transmembrane domains and two extracellular loops. The 
extracellular loops, whose sequences are distinct in different claudins, contribute to the formation 
of TJs. Several membrane proteins that participate in TJ-scaffolding bind to the C-terminal YV 
sequences of several claudins through their PDZ domains. As mentioned, among the proteins 
which directly interact with C-terminus of claudins ZO-1 has been described (Ikari et al., 2004). 
Moreover, it has been observed that JAMs regulate several signaling mechanisms that control 
epithelial polarization. JAMs can also interact with ZO-1 and F-actin plaques are also found near 
the cytoplasmic domains of JAMs to promote firm adhesions (Fig. 29B). Finally, occludin is a 
transmembrane protein also localized in the TJs. Occludin is likely to be involved in establishing 
the seal at the sites of junctional strands and it also interacts directly with ZO-1 among other 
proteins (Fig. 29C) (Matter et al., 2005).  
 
Our hypothesis is that MT2-MMP can be taking part of the TJ complex by its anchoring to the 
actin cytoskeleton though its binding to ZO-1. In such position, it can be participating directly or 
indirectly in the cleaving of TJ transmembrane proteins thus disturbing apico-basal polarity. In this 
sense, it has been seen that claudin 5 promotes proMMP-2 processing by MT2-MMP. Miyamori 
and coll. analyzed the effects of claudin 5 expression on activation of proMMP-2 by MT-MMPs in 
HEK293T cells. Expression of claudin 5 or MT2-MMP alone did not have any effect on proMMP-2 
processing. However, proMMP-2 activation was observed when claudin 5 cDNA was co-
transfected with MT2-MMP. In the authors´ opinion claudins may recruit MT2-MMP and proMMP-
2 favouring the cleavage of proMMP-2 (Miyamori et al., 2001). To investigate the possibility that 
MT2-MMP is affecting apico-basal polarity by its catalytic activity, a putative catalytically inactive 
MT2-MMP mutant has been generated (see Materials and Methods). After confirming that the 
mutated amino acid impairs MT2-MMP activity, clones expressing catalytically inactive MT2-MMP 
will be generated and checked for F-actin apical-basal polarity. Another complementary approach 
would be to use an MMP inhibitor (as GM6001/Ilomastat) to analyze if the apical-basal reduced F-
actin polarization is reverted when the inhibitor is present. 
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4. Global discussion     
 
      The original objective of this work was to get insight into redundant versus specific functions 
of MT-MMPs by their different association to cytosolic partners. Our work has identified three 
proteins that can bind some of them are common partners of all MT-MMPs and some others are 
specific for a subset of MT-MMPs. In Figure 30 the interacting partners of MT1- and MT2-MMP 
cytosolic tails described in this work and the cellular functions of these associations are 
summarized.  
 
      In the middle region of MT1-MMP the phosphorylation of its tyrosine is necessary for p130Cas 
binding and therefore Rac1 activation which leads to myeloid cell fusion. MT2-, MT3- and MT5-
MMP have also a tyrosine residue in the same position as MT1-MMP, then, a similar function 
could be expected. However, MT1-MMP seems to have a specific role in OC fusion as MT2-, 
MT3- nor MT5-MMP are not able to compensate MT1-MMP myeloid fusion promotion in the MT1-
MMP deficient mice. MT2-MMP expression in myeloid cells was checked and similar levels were 
found in WT and MT1-MMP deficient mice (data not shown). In conclusion, MT2-MMP although it 
shares this putative phosphorylable tyrosine with MT1-MMP, can not overcome the lack of MT1-
MMP.  
 
Juxtamembrane polybasic region of MT1-MMP acts as a key binding domain for moesin 
interaction and this association seems to be involved in the regulation of MT1-MMP presence at 
the plasma membrane. MT1-MMP/moesin binding could be involved in MT1-MMP endocytosis as 
different works have been previously shown the relevance of MT1-MMP cytosolic tail in MT1-
MMP endocytosis and intracellular trafficking (Uekita et al., 2001; Smith-Pearson et al., 2010; 
Radichev et al., 2009; Rozanov et al., 2002b). Moreover, MT2- and MT3-MMP also bound in vitro 
to N-terminal moesin. As they have the same polybasic cluster structure than MT1-MMP it can be 
Figure 29: Schematic representation of the basic structural transmembrane 
components of tight junctions. ZO-1 is important for binding claudins, 
occluding and JAM-1 participating in the formation of tight junctional strands 
(Adapted from(Niessen, 2007)
Discussion 
 
 82
thought that the findings obtained for MT1-MMP can also occur in the case of MT2- and MT3-
MMP. Interestingly, MT3-MMP has been seen to co-recycle with MT1-MMP (Wang et al., 2004b). 
 
      Finally, MT2-MMP C-terminus has been found to interact with ZO-1 PDZ domains and this 
binding affects F-actin polarity of epithelial (MDCK) monolayers. MT1-MMP, despite it also has a 
PDZ binding motif, is unable to bind to ZO-1. This difference of affinity of MT1-MMP and MT2-
MMP to PDZ proteins can be relevant to determine not only the binding to ZO-1 but also their 
binding to other proteins with PDZ domains, which can therefore modulate their specific functions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 30: Diagram of the MT-MMP cytosolic tail interacting proteins described in this work. Identified MT-
MMP key cytosolic residues for these interactions and their possible cellular function are also shown. 
p130Cas binds to the unique tyrosine residue of MT1-MMP cytosolic tail and this binding is important for 
myeloid cell migration and function. MT1-MMP binds to moesin N-terminal domain and juxtamembrane 
polybasic region of MT1-MMP cytosolic tail plays a key role for this interaction. Moreover, MT2-MMP also 
binds to moesin and it can be speculated as it shares the same moesin binding region binding can occur 
also at this site. MT1-MMP subcellular localization might be regulated by this association. ZO-1 does not 
bind to MT1-MMP cytosolic tail because of the presence of a lysine in its PDZ binding motif. On the 
contrary, MT2-MMP binds to the three ZO-1 PDZ domains and the last two residues (tryptophan and valine) 
of MT2-MMP cytosolic tail play a key role for this interaction. Moreover, this interaction affects the polarity 
of epithelial cells (MDCK).  
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1. MT1-MMP is required for proper p130Cas localization at the cell membrane. 
 
2. The unique MT1-MMP cytosolic tyrosine is essential for MT1-MMP binding to p130Cas. 
 
3. MT1-MMP cytosolic tyrosine participates in MT1-MMP promotion of myeloid progenitor 
fusion. 
 
4. MT1-MMP, MT2-MMP and MT3-MMP cytosolic tails bind in vitro to moesin N-terminus. 
 
5. Juxtamembrane polybasic cluster of MT1-MMP (RRH563) is essential for its binding to 
moesin. Middle MT1-MMP polybasic cluster (RR569) also participates in this interaction.  
 
6. MT2-MMP, MT3-MMP and MT5-MMP interact with ZO-1. MT1-MMP affinity for ZO-1 is 
very low.  
 
7. MT2-MMP can bind to each of the three PDZ domains of ZO-1 showing more affinity for 
PDZ2 and PDZ1 and less for PDZ3.  
 
8. MT2-MMP binds to ZO-1 through its PDZ binding motif being the tryptophan residue 
located at this site the responsible of the different affinity of MT1-MMP and MT2-MMP for 
ZO-1.  
 
9. MT2-MMP and ZO-1 colocalize in the lamella and in the perinuclear region of breast 
cancer cells. 
 
10. MT2-MMP colocalizes with ZO-1 at cell-cell junctions of polarized stable transfectant 
MT2-MMP-MDCK cells affecting apico-basal polarity of F-actin.  
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1. MT1-MMP es necesaria para la correcta localización de p130Cas en la membrana 
celular. 
 
2. La única tirosina citosólica de MT1-MMP es esencial para la unión de MT1-MMP a 
p130Cas. 
 
3. La tirosina citosólica de MT1-MMP participa en la fusión de los progenitores mieloides 
potenciada por MT1-MMP. 
 
4. Las colas citosólicas de MT1-MMP, MT2-MMP y MT3-MMP se unen in vitro al extremo N-
terminal de moesina. 
 
5. El grupo polibásico yuxtamembranal de MT1-MMP (RRH563) es esencial para su unión a 
moesina. El grupo polibásico central de MT1-MMP (RR569) participa también en esta 
interacción.  
 
6. MT2-MMP, MT3-MMP y MT5-MMP interaccionan con ZO-1. La afinidad de MT1-MMP por 
ZO-1 es muy baja.  
 
7. MT2-MMP se une a cada uno de los tres dominios PDZ de ZO-1 mostrando más afinidad 
por PDZ2 y PDZ1 y menos por PDZ3. 
 
8. MT2-MMP se une a ZO-1 a través de su motivo de unión a dominios PDZ siendo el 
residuo de triptófano localizado en este lugar el responsable de la diferente afinidad de 
MT1-MMP y MT2-MMP por ZO-1. 
 
9. MT2-MMP y ZO-1 colocalizan en la lamela y en la región perinuclear de células de cáncer 
de mama. 
 
10. MT2-MMP colocaliza con ZO-1 en las uniones celulares de MDCK transfectantes 
estables de MT2-MMP afectando a la polaridad apico-basal de la F-actina. 
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Cell fusion is essential for fertilization, myotube
formation, and inflammation. Macrophages fuse
under various circumstances, but the molecular
signals involved in the distinct steps of their fusion
are not fully characterized. Using null mice and
derived cells, we show that the protease MT1-MMP
is necessary for macrophage fusion during osteo-
clast and giant-cell formation in vitro and in vivo.
Specifically, MT1-MMP is required for lamellipodia
formation and for proper cell morphology and
motility of bone marrow myeloid progenitors prior
to membrane fusion. These functions of MT1-MMP
do not depend on MT1-MMP catalytic activity or
downstream pro-MMP-2 activation. Instead, MT1-
MMP null cells show a decreased Rac1 activity and
reduced membrane targeting of Rac1 and the
adaptor protein p130Cas. Retroviral rescue experi-
ments and protein binding assays delineate
a signaling pathway in which MT1-MMP, via its cyto-
solic tail, contributes to macrophage migration and
fusion by regulating Rac1 activity through an associ-
ation with p130Cas.
INTRODUCTION
Cell fusion is fundamental in processes such as fertilization and
vertebrate myogenesis (Chen et al., 2007), and may also be
important in inflammation (Johansson et al., 2008; Nygren
et al., 2008). Under certain circumstances, cells of the mono-
cyte/macrophage lineage can fuse, giving rise to osteoclasts
(OC) in bone or giant cells (GC) in inflamed soft tissues. These
multinucleated derivatives acquire specialized functions in
bone resorption and engulfment of pathogens and foreign
bodies, respectively (Vignery, 2005). Several diseases of the
adult skeleton are related to disturbances in OC function, either
through increased activity (bone metastasis, osteoporosis,
Paget’s disease) or decreased activity (osteopetrosis).DeveMolecules can contribute to cell fusion by either directly
participating in membrane fusion or by affecting earlier steps in
the process (Oren-Suissa and Podbilewicz, 2007; Primakoff
and Myles, 2007). The signaling pathways involved in cell-cell
fusion have mostly been characterized in yeast and inverte-
brates; much less is known about the regulation of fusion by
mammalian cells, and by macrophages in particular (Chen
et al., 2007). For example, EFF-1 and AFF-1 act as direct
membrane fusogens during Caenorhabditis elegans develop-
ment (Mohler et al., 2002; Sapir et al., 2007), but themechanisms
bywhich proteins such as DC-STAMP, the d2 isoform v-ATPase,
and CD200 contribute to macrophage fusion remain undefined
(Cui et al., 2007; Lee et al., 2006; Yagi et al., 2005). One central
issue is how competent cells come into contact. In the case of
myotubes, the myogenic precursors are already in close prox-
imity, whereas sperm-egg fusion is dependent on spermmotility;
however, the mechanisms by which OC and GC precursors
achieve proximity are poorly understood.
MMPs (matrix metalloproteinases) are endopeptidases capa-
ble of degrading a variety of extracellular matrix components
and of modulating the activity of several secreted and cell-
surface proteins (Page-McCaw et al., 2007). MT1-MMP
(membrane type 1-MMP) is a membrane-anchored collage-
nase that plays important roles in pathophysiological settings,
including the development of skeletal, lung, and adipose
tissue, angiogenesis, and tumor invasion (Chun et al., 2006;
Holmbeck et al., 1999; Oblander et al., 2005; Sabeh et al.,
2004; Zhou et al., 2000). Here we report that MT1-MMP, inde-
pendent of its catalytic activity, regulates Rac1 signaling in
myeloid cells, thereby contributing to their migration and fusion
during osteoclastogenesis and GC formation in vitro and
in vivo.
RESULTS
MT1-MMP Null Myeloid Cells Are Defective
for OC Multinucleation In Vitro and In Vivo
MT1-MMP participates in leukocyte migration (Matias-Roman
et al., 2005; Yang et al., 2006), and we therefore analyzed hema-
topoietic development in MT1-MMP null mice. These mice die
2 weeks after birth, so 8-day-old mice were used for all anal-
yses. Flow cytometry showed that the percentage of cellslopmental Cell 18, 77–89, January 19, 2010 ª2010 Elsevier Inc. 77
